Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CASQ2,Calsequestrin-2,Lifestyle factors,X1050.Time spend outdoors in summer,44952,-0.0313544015029875,0.0264031104711984,-0.0831044980265364,0.0203956950205615,0.235033262409652
CASQ2,Calsequestrin-2,Lifestyle factors,X1060.Time spent outdoors in winter,41818,-0.0406346001744491,0.0294257940004401,-0.0983091564153117,0.0170399560664134,0.167321448148487
CASQ2,Calsequestrin-2,Physical activities,X1070.Time spent watching television (TV),45974,0.043353272340859,0.0259492754050451,-0.00750730745302932,0.0942138521347474,0.0947964869918462
CASQ2,Calsequestrin-2,Physical activities,X1080.Time spent using computer,41782,-0.0603674675855276,0.0276910214702666,-0.11464186966725,-0.00609306550380505,0.0292676432591552
CASQ2,Calsequestrin-2,Physical activities,X1090.Time spent driving,40855,-0.0185125428801039,0.0293304245530468,-0.0760001750040756,0.0389750892438679,0.52793655307711
CASQ2,Calsequestrin-2,Lifestyle factors,X1160.Sleep duration,47480,0.00206634447223276,0.0242438753822078,-0.0454516512768945,0.04958434022136,0.932077985211324
CASQ2,Calsequestrin-2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,32424,0.0204933402643134,0.0173714065244395,-0.0135546165235881,0.0545412970522148,0.238145635878401
CASQ2,Calsequestrin-2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,32424,0.00350638422087527,0.0171188973552069,-0.0300466545953303,0.0370594230370808,0.83771344451385
CASQ2,Calsequestrin-2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,32424,-0.0154043463455683,0.0198355374276997,-0.0542819997038597,0.023473307012723,0.437414227216254
CASQ2,Calsequestrin-2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,32424,0.00352272359933269,0.0206567110186181,-0.0369644299971589,0.0440098771958243,0.864592245209278
CASQ2,Calsequestrin-2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,32424,-0.0104809686586147,0.02110448461055,-0.0518457584952927,0.0308838211780633,0.619467804764397
CASQ2,Calsequestrin-2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,32424,-0.0618611016152291,0.0403450538824846,-0.140937407224899,0.0172152039944406,0.125238707189831
CASQ2,Calsequestrin-2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,32424,-0.0183870577284297,0.0412364074248599,-0.0992104162811552,0.0624363008242957,0.655685245059084
CASQ2,Calsequestrin-2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,32424,0.00525315392274385,0.0296647892993985,-0.0528898331040772,0.0633961409495649,0.859446746116043
CASQ2,Calsequestrin-2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,32424,-0.010154626528793,0.0221298837327045,-0.0535291986448938,0.0332199455873078,0.646342842525798
CASQ2,Calsequestrin-2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,32424,-0.000872014187849143,0.0154743335427297,-0.0312017079315993,0.029457679555901,0.95506247528272
CASQ2,Calsequestrin-2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,32424,0.0278998601658178,0.0219298827341767,-0.0150827099931685,0.0708824303248041,0.203325865445454
CASQ2,Calsequestrin-2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,32424,-0.00150992383937277,0.0125546210230732,-0.0261169810445962,0.0230971333658507,0.904273378480208
CASQ2,Calsequestrin-2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,32424,0.00713133637006914,0.0160706770507952,-0.0243671906494894,0.0386298633896276,0.657235747849197
CASQ2,Calsequestrin-2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,32424,0.0109943412045129,0.0243011041264134,-0.0366358228832574,0.0586245052922832,0.650976843664812
CASQ2,Calsequestrin-2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,32424,-0.0184690249007522,0.0226550010322046,-0.0628728269238732,0.0259347771223689,0.414963632230057
CASQ2,Calsequestrin-2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,32424,0.0359849989950562,0.0279340559678467,-0.0187657507019233,0.0907357486920358,0.197706818768267
CASQ2,Calsequestrin-2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,32424,0.00479157330205631,0.0271845400089818,-0.0484901251155481,0.0580732717196607,0.860093093596927
CASQ2,Calsequestrin-2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,32424,-0.00172160755726067,0.0179308547688143,-0.0368660829041367,0.0334228677896153,0.923511945132234
CASQ2,Calsequestrin-2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,32424,-0.0110002791846865,0.0168656660278474,-0.0440569845992675,0.0220564262298945,0.514270856206771
CASQ2,Calsequestrin-2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,32424,-0.0273426755381877,0.0208838254571487,-0.0682749734341991,0.0135896223578238,0.190476260440118
CASQ2,Calsequestrin-2,Health and medical history,X120040.Fatigue severity over the past week,32433,0.00511183898873961,0.0416064301518412,-0.0764367641088691,0.0866604420863483,0.902219452579362
CASQ2,Calsequestrin-2,Health and medical history,X120041.Waking unrefreshed severity over the past week,32435,0.0324207144642822,0.0414222861661364,-0.0487669664213451,0.11360839534991,0.433832137351596
CASQ2,Calsequestrin-2,Health and medical history,X120042.Cognitive symptoms severity over the past week,32433,0.00543637872158703,0.0450632100566085,-0.0828875129893656,0.0937602704325396,0.903979837645268
CASQ2,Calsequestrin-2,Health and medical history,X120098.Mobility problems today,32437,0.0568481937295913,0.0492288782292511,-0.0396404075997408,0.153336795058923,0.24821545990812
CASQ2,Calsequestrin-2,Health and medical history,X120099.Self-care problems today,32437,-0.124499113572594,0.0859517117059437,-0.292964468516244,0.0439662413710556,0.147520144248345
CASQ2,Calsequestrin-2,Health and medical history,X120100.Problems doing usual activities,32437,0.0202952580262458,0.0469526956685442,-0.0717320254841007,0.112322541536592,0.665571284713974
CASQ2,Calsequestrin-2,Health and medical history,X120101.Pain or discomfort today,32437,-0.0528641637242455,0.0419832162767788,-0.135151267626732,0.0294229401782411,0.208001860854753
CASQ2,Calsequestrin-2,Health and medical history,X120102.Anxiety or depression today,32437,-0.025364841944133,0.0496182806306408,-0.122616671980189,0.0718869880919229,0.609224508009817
CASQ2,Calsequestrin-2,Health and medical history,X120103.Scale to indicate how health is today,32406,0.00301398000231576,0.00540317533451561,-0.00757624365333484,0.0136042036579664,0.576984350128658
CASQ2,Calsequestrin-2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,32421,0.0559893947420632,0.0484102483298218,-0.0388946919843874,0.150873481468514,0.247484131678689
CASQ2,Calsequestrin-2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",32407,0.0357704787709626,0.0495273620524585,-0.0613031508518559,0.132844108393781,0.470168724213933
CASQ2,Calsequestrin-2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",32426,0.0517236474872113,0.0412602086487129,-0.0291463614642661,0.132593656438689,0.21002297450462
CASQ2,Calsequestrin-2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,32429,0.0219507964585141,0.042418634240197,-0.061189726652272,0.1050913195693,0.604834461117609
CASQ2,Calsequestrin-2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,32423,0.0195007165337133,0.0513717505222175,-0.0811879144898329,0.12018934755726,0.704251775882184
CASQ2,Calsequestrin-2,Health and medical history,X120109.Feeling bad about self over the last two weeks,32404,-0.0110941572658213,0.052961214228908,-0.114898137154481,0.0927098226228384,0.834080869231777
CASQ2,Calsequestrin-2,Health and medical history,X120110.Trouble concentrating over the last two weeks,32429,0.0716094156659607,0.0507897332006144,-0.0279384614072435,0.171157292739165,0.158599870194706
CASQ2,Calsequestrin-2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,32418,0.0135386629675265,0.0790610615883066,-0.141421017745554,0.168498343680608,0.864036651744675
CASQ2,Calsequestrin-2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,32374,-0.186032320173619,0.120133879173615,-0.421494723353905,0.0494300830066658,0.121529109147313
CASQ2,Calsequestrin-2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",29978,0.0515533050949334,0.0541710838044007,-0.0546220191616919,0.157728629351559,0.341299074520347
CASQ2,Calsequestrin-2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,44842,-0.131768935161546,0.0630260609241112,-0.255300014572804,-0.00823785575028778,0.0365664696318442
CASQ2,Calsequestrin-2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,43714,-0.0841032269491775,0.0365478104921503,-0.155736935513792,-0.012469518384563,0.0213915559617258
CASQ2,Calsequestrin-2,Diet and food preferences,X1289.Cooked vegetable intake,46618,-0.0288931902557291,0.0248550073063131,-0.0776090045761028,0.0198226240646446,0.245056958926594
CASQ2,Calsequestrin-2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,46177,-0.0278791644153378,0.0263401958422061,-0.0795059482660617,0.0237476194353862,0.289872445662822
CASQ2,Calsequestrin-2,Diet and food preferences,X1309.Fresh fruit intake,46615,-0.0239316520421989,0.0265264119615116,-0.0759234194867615,0.0280601154023638,0.366969731787777
CASQ2,Calsequestrin-2,Diet and food preferences,X1319.Dried fruit intake,45305,-0.0371918070136973,0.0282178366208337,-0.0924987667905314,0.0181151527631369,0.187509442349179
CASQ2,Calsequestrin-2,Health and medical history,X134.Number of self-reported cancers,47678,-0.0165233967531084,0.0551365665362765,-0.12459106716421,0.0915442736579936,0.764422895597484
CASQ2,Calsequestrin-2,Health and medical history,X135.Number of self-reported non-cancer illnesses,47678,-0.00166810314814544,0.0244806293910753,-0.0496501367546531,0.0463139304583622,0.94567498655797
CASQ2,Calsequestrin-2,Health and medical history,"X136.Number of operations, self-reported",47678,-0.00500674428754047,0.0244396907219427,-0.0529085381025481,0.0428950495274671,0.837682323385121
CASQ2,Calsequestrin-2,Health and medical history,X137.Number of treatments or medications taken,47678,-0.00702292226707493,0.0242965757236444,-0.0546442106854179,0.0405983661512681,0.77254572384421
CASQ2,Calsequestrin-2,Diet and food preferences,X1438.Bread intake,46935,0.000982887652004874,0.00342229431401093,-0.00572480920345655,0.00769058450746629,0.773960708109857
CASQ2,Calsequestrin-2,Diet and food preferences,X1458.Cereal intake,46261,0.00834085637977737,0.0253007100808087,-0.0412485353786076,0.0579302481381624,0.741653264306821
CASQ2,Calsequestrin-2,Diet and food preferences,X1488.Tea intake,46739,-0.00163545834441254,0.00324542828517428,-0.00799649778335414,0.00472558109452906,0.614317657441708
CASQ2,Calsequestrin-2,Diet and food preferences,X1498.Coffee intake,45734,-0.030603078888944,0.0253441330474265,-0.0802775796619,0.019071421884012,0.227252121116636
CASQ2,Calsequestrin-2,Diet and food preferences,X1528.Water intake,46011,0.00338021997848564,0.0259968633710549,-0.0475736322287819,0.0543340721857532,0.896548503196292
CASQ2,Calsequestrin-2,Lifestyle factors,X1568.Average weekly red wine intake,39970,-0.0498010139082304,0.0293483769266223,-0.10732383268441,0.00772180486794933,0.0897364772077535
CASQ2,Calsequestrin-2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,39965,-0.00442840508452154,0.0301135771710237,-0.063451016339728,0.054594206170685,0.883089060295837
CASQ2,Calsequestrin-2,Lifestyle factors,X1588.Average weekly beer plus cider intake,40006,0.0127311630032639,0.0334415016790029,-0.0528141802875817,0.0782765062941095,0.703431247890317
CASQ2,Calsequestrin-2,Lifestyle factors,X1598.Average weekly spirits intake,39942,0.0346811240502736,0.0327122291999128,-0.0294348451815554,0.0987970932821026,0.289074846516961
CASQ2,Calsequestrin-2,Lifestyle factors,X1608.Average weekly fortified wine intake,40000,0.0384074146867028,0.0589820615297855,-0.0771974259116768,0.154012255285082,0.514945306199697
CASQ2,Calsequestrin-2,Lifestyle factors,X1737.Childhood sunburn occasions,42171,-0.0195207738962801,0.0289746109781518,-0.0763110114134577,0.0372694636208975,0.500497870627715
CASQ2,Calsequestrin-2,Health and medical history,X1807.Father's age at death,38101,-0.000889841050531204,0.00449970521040631,-0.00970926326292758,0.00792958116186517,0.843239256958457
CASQ2,Calsequestrin-2,Health and medical history,X1845.Mother's age,37438,0.00618960225472609,0.00705787633050275,-0.0076438353530593,0.0200230398625115,0.380514104366999
CASQ2,Calsequestrin-2,Health and medical history,X1873.Number of full brothers,47252,0.0144047218774485,0.0243988778595598,-0.0334170787272887,0.0622265224821856,0.554938532682573
CASQ2,Calsequestrin-2,Health and medical history,X1883.Number of full sisters,47251,-0.0306156573111102,0.0244239435515131,-0.0784865866720758,0.0172552720498554,0.210032693799805
CASQ2,Calsequestrin-2,Physical measures,X20015.Sitting height,47480,0.000698471445510165,0.00431286179090497,-0.00775473766466358,0.00915168055568392,0.871345978301475
CASQ2,Calsequestrin-2,Cognitive function,X20016.Fluid intelligence score,31425,-0.0149419297845803,0.0390320171501724,-0.0914446833989182,0.0615608238297577,0.70186983614383
CASQ2,Calsequestrin-2,Cognitive function,X20018.Prospective memory result,31720,-0.0709185912491972,0.0578856507754056,-0.184374466768992,0.0425372842705979,0.220555515719466
CASQ2,Calsequestrin-2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),31361,-0.00656536357209314,0.00625854503822713,-0.0188321118470183,0.00570138470283203,0.294200897889255
CASQ2,Calsequestrin-2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),31363,-0.0154772264426909,0.00624315418339756,-0.0277138086421502,-0.00324064424323172,0.0131942908504328
CASQ2,Calsequestrin-2,Cognitive function,X20023.Mean time to correctly identify matches,47404,-0.00129939797167464,0.00345403189943221,-0.00806930049456177,0.0054705045512125,0.706773505307833
CASQ2,Calsequestrin-2,Health and medical history,X20107#1.Illnesses of father_Heart disease,44932,-0.00282831060259164,0.00739929601253575,-0.0173309307871617,0.0116743095819784,0.702286839131327
CASQ2,Calsequestrin-2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,44562,0.00155697523760699,0.0169443102735294,-0.0316538728985107,0.0347678233737247,0.92678808103385
CASQ2,Calsequestrin-2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,44535,0.00253607483285999,0.0226184147710287,-0.0417960181183563,0.0468681677840763,0.910725906912785
CASQ2,Calsequestrin-2,Health and medical history,X20107#12.Illnesses of father_Severe depression,44561,0.0125199103651347,0.0171537543716186,-0.0211014482032378,0.0461412689335072,0.465481485941139
CASQ2,Calsequestrin-2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,44564,0.0027562296687536,0.0126473829034794,-0.0220326408220661,0.0275451001595733,0.827486692481013
CASQ2,Calsequestrin-2,Health and medical history,X20107#2.Illnesses of father_Stroke,44698,-0.00892610968076116,0.00975975406368588,-0.0280552276455855,0.0102030082840632,0.360420925398121
CASQ2,Calsequestrin-2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,44651,-0.00905325093752192,0.0126805886629794,-0.0339072047169616,0.0158007028419178,0.475268811007155
CASQ2,Calsequestrin-2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,44566,0.0124505803493884,0.0152824973411495,-0.0175031144392647,0.0424042751380414,0.415256054459004
CASQ2,Calsequestrin-2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,44673,-0.00294830701786105,0.0120852233109939,-0.0266353447074091,0.020738730671687,0.80726446426342
CASQ2,Calsequestrin-2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,44792,-0.0084338091212984,0.00767883306295989,-0.0234843219246998,0.00661670368210298,0.272077801827215
CASQ2,Calsequestrin-2,Health and medical history,X20107#9.Illnesses of father_Diabetes,44666,-0.00670394465739021,0.0104594289214921,-0.0272044253435147,0.0137965360287343,0.521563862718179
CASQ2,Calsequestrin-2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,45807,0.00903228695973475,0.00892755617130961,-0.00846572313603208,0.0265302970555016,0.311677755603315
CASQ2,Calsequestrin-2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,45701,-0.0198315902869246,0.0144621429618679,-0.0481773904921856,0.00851420991833648,0.170303006726553
CASQ2,Calsequestrin-2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,45651,-0.0240332444693248,0.0306278992364759,-0.0840639269728176,0.0359974380341679,0.432646975274489
CASQ2,Calsequestrin-2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,45690,0.00903857656403862,0.012994230978896,-0.0164301161545974,0.0345072692826747,0.486696918777329
CASQ2,Calsequestrin-2,Health and medical history,X20110#2.Illnesses of mother_Stroke,45754,-0.0103623783267574,0.0106394560905428,-0.0312157122642212,0.0104909556107064,0.330088389499926
CASQ2,Calsequestrin-2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,45696,-0.0114316133154984,0.0173352416802792,-0.0454086870088457,0.0225454603778489,0.509617938609919
CASQ2,Calsequestrin-2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,45673,-0.00423312782181048,0.016298829711822,-0.0361788340569817,0.0277125784133607,0.795082415536593
CASQ2,Calsequestrin-2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,45703,-0.00489603102751897,0.0123906451455277,-0.0291816955127533,0.0193896334577154,0.692743934517066
CASQ2,Calsequestrin-2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,45711,-0.0092976447695281,0.014571947677958,-0.0378586622183258,0.0192633726792696,0.523447213664723
CASQ2,Calsequestrin-2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,45900,-0.00232867855930819,0.00701567011926904,-0.0160793919930755,0.0114220348744591,0.73994880586411
CASQ2,Calsequestrin-2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,45755,-0.00981728961171911,0.0108489264451157,-0.0310811854441459,0.0114466062207077,0.365523632107584
CASQ2,Calsequestrin-2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43416,0.00983860386809665,0.0142933453614347,-0.0181763530403153,0.0378535607765086,0.491250275633457
CASQ2,Calsequestrin-2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43320,-0.0976536326199016,0.0805467729299542,-0.255525307562612,0.0602180423228086,0.225380075431918
CASQ2,Calsequestrin-2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43319,0.0101469853839483,0.0676305172399065,-0.122408828406269,0.142702799174165,0.880738081639569
CASQ2,Calsequestrin-2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43395,0.0150440452750432,0.0131740115520561,-0.0107770173669867,0.0408651079170732,0.253489343618591
CASQ2,Calsequestrin-2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43323,0.0200821873958958,0.045088754044832,-0.0682917705319749,0.108456145323767,0.656041172917672
CASQ2,Calsequestrin-2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43338,-0.0220413314333344,0.0246208432724607,-0.0702981842473574,0.0262155213806887,0.370674911491909
CASQ2,Calsequestrin-2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43322,-0.00266166206832385,0.0322071447528481,-0.0657876657839061,0.0604643416472584,0.934137073662326
CASQ2,Calsequestrin-2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43335,-0.0188571822407413,0.0294171466501071,-0.0765147896749512,0.0388004251934686,0.521512750843334
CASQ2,Calsequestrin-2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43335,-0.00588515916899423,0.0195942937513744,-0.0442899749216881,0.0325196565836996,0.763912896465987
CASQ2,Calsequestrin-2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43342,0.00184878044838673,0.026052814152021,-0.0492147352895744,0.0529122961863479,0.943428096363697
CASQ2,Calsequestrin-2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43492,-0.00183270817087006,0.0092159846643012,-0.0198960381129004,0.0162306217711603,0.842372837154395
CASQ2,Calsequestrin-2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43399,0.00795451379147576,0.0134280333877206,-0.0183644316484567,0.0342734592314082,0.553602244402608
CASQ2,Calsequestrin-2,Mental health,X20127.Neuroticism score,42959,-0.0283263587547398,0.0255790973126547,-0.078461389487543,0.0218086719780635,0.268133858757363
CASQ2,Calsequestrin-2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,31425,0.000449724635889278,0.0397712651826646,-0.0775019551221334,0.0784014043939119,0.990978189426415
CASQ2,Calsequestrin-2,Lifestyle factors,X20161.Pack years of smoking,30534,0.0101889958423886,0.00706124171891692,-0.00365103792668857,0.0240290296114658,0.14908240056988
CASQ2,Calsequestrin-2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,30534,0.00996973050192937,0.00660117411701294,-0.002968570767416,0.0229080317712747,0.131015112379385
CASQ2,Calsequestrin-2,Cognitive function,X20191.Fluid intelligence score,29966,0.0526777186715969,0.0464803916683888,-0.0384238489984451,0.143779286341639,0.257119411897734
CASQ2,Calsequestrin-2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,29966,0.0476667883845472,0.0470931185393346,-0.0446357239525486,0.139969300721643,0.311491414438803
CASQ2,Calsequestrin-2,Cognitive function,X20240.Maximum digits remembered correctly,29433,0.0526029886240224,0.0508252749465621,-0.0470145502712394,0.152220527519284,0.300724642356623
CASQ2,Calsequestrin-2,Physical measures,X20255.Spirometry QC measure,41555,-0.0476899679286648,0.0328768125423258,-0.112128520511623,0.0167485846542937,0.146918628982189
CASQ2,Calsequestrin-2,Eye measures,X20261.avMSE,29061,-0.00849745294017487,0.00777660777174952,-0.0237396041728039,0.0067446982924542,0.274578768396246
CASQ2,Calsequestrin-2,Eye measures,X20262.Myopia diagnosis,29061,0.0743714206102321,0.0558656813864729,-0.0351253149072548,0.183868156127719,0.183163756037732
CASQ2,Calsequestrin-2,NMR metabolomics,X20280.Glucose-lactate,36992,-0.00877842373989379,0.00452616593283029,-0.0176497089682412,9.28614884535793e-05,0.0524638910720456
CASQ2,Calsequestrin-2,NMR metabolomics,X20281.Spectrometer-corrected alanine,37017,0.000324271045283425,0.00447028093447277,-0.00843747958628321,0.00908602167685006,0.942173834383787
CASQ2,Calsequestrin-2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,31268,0.00362297404002863,0.0203723086057043,-0.0363067508271518,0.0435526989072091,0.858854933793245
CASQ2,Calsequestrin-2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,31266,-0.0705486377679197,0.0413718349570567,-0.151637434283751,0.0105401587479113,0.0881928257417935
CASQ2,Calsequestrin-2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),31267,-0.0627274016194495,0.0459735757268834,-0.152835610044141,0.0273808068052419,0.172475941376417
CASQ2,Calsequestrin-2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),31267,0.0155211967515639,0.0196940297339204,-0.02307910152692,0.0541214950300479,0.430653578489944
CASQ2,Calsequestrin-2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),31267,-0.0048411655505759,0.0316163438955559,-0.0668091995858655,0.0571268684847137,0.878306044920919
CASQ2,Calsequestrin-2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,31271,-0.0739399254809573,0.04084058330903,-0.153987468766656,0.00610761780474138,0.0702661663333147
CASQ2,Calsequestrin-2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,31271,0.00103354533897439,0.0275338377072146,-0.0529327765671663,0.0549998672451151,0.970057628027639
CASQ2,Calsequestrin-2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,31271,-0.0130295824202086,0.0295423044596723,-0.0709324991611664,0.0448733343207492,0.659190914424966
CASQ2,Calsequestrin-2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,31271,0.0258489887984665,0.0457372168140771,-0.0637959561571246,0.115493933754058,0.571979916992359
CASQ2,Calsequestrin-2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,31271,-0.0689866120446654,0.0527425572276467,-0.172362024210853,0.0343888001215221,0.190918076208037
CASQ2,Calsequestrin-2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,31271,0.0150503487180539,0.030910827473443,-0.0455348731298944,0.0756355705660022,0.626346651759534
CASQ2,Calsequestrin-2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,31271,-0.0626752118186527,0.052146621705303,-0.164882590361047,0.0395321667237412,0.229439287372898
CASQ2,Calsequestrin-2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,31271,-0.0284107061755795,0.0386310936085288,-0.104127649648296,0.047306237297137,0.462097131707542
CASQ2,Calsequestrin-2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),31274,-0.0959243377714889,0.0533475309582519,-0.200485498449663,0.00863682290668484,0.0722014061258692
CASQ2,Calsequestrin-2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),31274,0.0242075824287938,0.0264092134402424,-0.0275544759140812,0.0759696407716689,0.359364286551475
CASQ2,Calsequestrin-2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),31274,-0.0216173334313809,0.0362535394052806,-0.0926742706657308,0.049439603802969,0.551005050020903
CASQ2,Calsequestrin-2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,31274,0.0479847207556798,0.0609071334148278,-0.0713932607373826,0.167362702248742,0.430818899078149
CASQ2,Calsequestrin-2,Diet and food preferences,X20600.Liking for adding salt to foods,33170,0.0655469770101925,0.0355322440323997,-0.00409622129331087,0.135190175313696,0.0651103180174153
CASQ2,Calsequestrin-2,Diet and food preferences,X20601.Liking for aniseed,33170,0.0810153749754825,0.0358985965134481,0.0106541258091242,0.151376624141841,0.0240446901064325
CASQ2,Calsequestrin-2,Diet and food preferences,X20602.Liking for apple juice,33170,0.0581231504528728,0.0355513818610624,-0.0115575579948095,0.127803858900555,0.102102695313676
CASQ2,Calsequestrin-2,Diet and food preferences,X20603.Liking for apples,33170,0.00669951222730113,0.0366085032909035,-0.0650531542228698,0.078452178677472,0.854798661143721
CASQ2,Calsequestrin-2,Diet and food preferences,X20604.Liking for asparagus,33170,-0.0187453092679971,0.0368377079208729,-0.090947216792908,0.0534565982569137,0.610861036453353
CASQ2,Calsequestrin-2,Diet and food preferences,X20605.Liking for aubergine,33170,0.0330382999006772,0.0362584923173123,-0.0380283450412549,0.104104944842609,0.362219986244569
CASQ2,Calsequestrin-2,Diet and food preferences,X20606.Liking for avocados,33170,0.0206034544707282,0.0360625471856579,-0.0500791380131612,0.0912860469546176,0.567792792627433
CASQ2,Calsequestrin-2,Diet and food preferences,X20607.Liking for bacon,33170,0.0410855506586491,0.0363897273597685,-0.0302383149664971,0.112409416283795,0.258909002328829
CASQ2,Calsequestrin-2,Diet and food preferences,X20608.Liking for baked or steamed fish,33170,-0.0247968723063685,0.0365390859444386,-0.0964134807574683,0.0468197361447312,0.497383101367157
CASQ2,Calsequestrin-2,Diet and food preferences,X20609.Liking for bananas,33170,0.0158673795150702,0.0372669622410753,-0.0571758664774373,0.0889106255075777,0.670280901077783
CASQ2,Calsequestrin-2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,33170,0.0135384073120354,0.0369689953731973,-0.0589208236194314,0.0859976382435021,0.714216881306754
CASQ2,Calsequestrin-2,Diet and food preferences,X20611.Liking for beef steak,33170,-0.0262965816918881,0.0367666519057143,-0.0983592194270881,0.0457660560433119,0.474485403778979
CASQ2,Calsequestrin-2,Diet and food preferences,X20612.Liking for beetroot,33170,-0.0130951930171029,0.0370014286935401,-0.0856179932564416,0.0594276072222357,0.723414002468487
CASQ2,Calsequestrin-2,Diet and food preferences,X20613.Liking for bell pepper,33170,0.0354670600560526,0.0367465086823166,-0.0365560969612879,0.107490217073393,0.3344788734449
CASQ2,Calsequestrin-2,Diet and food preferences,X20614.Liking for bicycling,33170,0.00984993227387228,0.035896345395158,-0.0605069047006375,0.080206769248382,0.783783870111701
CASQ2,Calsequestrin-2,Diet and food preferences,X20615.Liking for biscuits,33170,0.0266582152988626,0.0366045316188418,-0.0450866666740674,0.0984030972717926,0.46646276064104
CASQ2,Calsequestrin-2,Diet and food preferences,X20616.Liking for bitter foods,33170,0.0303989947725771,0.0357507717662847,-0.0396725178893409,0.100470507434495,0.395178439154609
CASQ2,Calsequestrin-2,Diet and food preferences,X20617.Liking for bitter or ale,33170,0.00622994554184862,0.0365634982906838,-0.0654345111078915,0.0778944021915888,0.864709484837674
CASQ2,Calsequestrin-2,Diet and food preferences,X20618.Liking for black olives,33170,0.0109069260329063,0.0361455025089935,-0.059938258884721,0.0817521109505336,0.762848960034459
CASQ2,Calsequestrin-2,Diet and food preferences,X20619.Liking for black pepper,33170,-0.0222380416397255,0.0361618813472042,-0.0931153290802457,0.0486392458007947,0.538597439777046
CASQ2,Calsequestrin-2,Diet and food preferences,X20620.Liking for blue cheese,33170,0.0399110837970094,0.0353067256459165,-0.0292900984689869,0.109112266063006,0.258332554835947
CASQ2,Calsequestrin-2,Diet and food preferences,X20621.Liking for bolognese sauce,33170,0.052467357914334,0.0375266498150487,-0.0210848757231614,0.126019591551829,0.162105586208576
CASQ2,Calsequestrin-2,Diet and food preferences,X20622.Liking for broad beans,33170,-0.00366673913587249,0.0361384155228593,-0.0744980335606767,0.0671645552889317,0.919184519907103
CASQ2,Calsequestrin-2,Diet and food preferences,X20623.Liking for broccoli,33170,0.000544610920335896,0.0365596757823698,-0.0711123536131089,0.0722015754537807,0.98811507804072
CASQ2,Calsequestrin-2,Diet and food preferences,X20624.Liking for brown rice,33170,0.0331258379944728,0.0365952336910454,-0.0386008200399762,0.104852496028922,0.365385313460584
CASQ2,Calsequestrin-2,Diet and food preferences,X20625.Liking for brussel sprouts,33170,0.0515591083866286,0.0362179042309204,-0.0194279839059753,0.122546200679233,0.154601438014201
CASQ2,Calsequestrin-2,Diet and food preferences,X20626.Liking for burgers (meat),33170,-0.022206483699711,0.0361111203975115,-0.0929842796788336,0.0485713122794116,0.538603695735563
CASQ2,Calsequestrin-2,Diet and food preferences,X20627.Liking for burn of spicy foods,33170,-0.0222416775552172,0.0366252730614212,-0.0940272127556027,0.0495438576451683,0.543682076080573
CASQ2,Calsequestrin-2,Diet and food preferences,X20628.Liking for butter on bread,33170,0.11173509863385,0.0372107677708194,0.0388019938030442,0.184668203464656,0.00268252285765178
CASQ2,Calsequestrin-2,Diet and food preferences,X20629.Liking for butternut squash,33170,0.0304700330617216,0.0358690293685158,-0.0398332645005693,0.100773330624013,0.395635963604261
CASQ2,Calsequestrin-2,Diet and food preferences,X20630.Liking for cabbage,33170,0.0417922314699265,0.0367158018908786,-0.0301707402361955,0.113755203176048,0.255040080767338
CASQ2,Calsequestrin-2,Diet and food preferences,X20631.Liking for cake,33170,0.0485746391921507,0.03634361676971,-0.0226588496764809,0.119808128060782,0.181406052974351
CASQ2,Calsequestrin-2,Diet and food preferences,X20632.Liking for cake icing,33170,0.0759735075636087,0.0373307277305096,0.00280528121180985,0.149141733915408,0.0418644082874426
CASQ2,Calsequestrin-2,Diet and food preferences,X20633.Liking for capers,33170,0.0392699155840474,0.0364924582152374,-0.0322553025178178,0.110795133685913,0.281905775147049
CASQ2,Calsequestrin-2,Diet and food preferences,X20634.Liking for cauliflower,33170,0.00218261777258173,0.036394415871904,-0.06915043733635,0.0735156728815135,0.952179839472185
CASQ2,Calsequestrin-2,Diet and food preferences,X20635.Liking for cereal or granola bar,33170,-0.039276439663502,0.0359552191703761,-0.109748669237439,0.0311957899104351,0.274698346218553
CASQ2,Calsequestrin-2,Diet and food preferences,X20636.Liking for cheesecake,33170,0.0554336624157752,0.0366986171626904,-0.0164956272230979,0.127362952054648,0.130947072691786
CASQ2,Calsequestrin-2,Diet and food preferences,X20637.Liking for cherries,33170,0.0629386141720049,0.0376091877342297,-0.0107753937870853,0.136652622131095,0.0942644238440749
CASQ2,Calsequestrin-2,Diet and food preferences,X20638.Liking for chicken,33170,-0.0296761343670604,0.0375702559847231,-0.103313836097118,0.0439615673629968,0.429615803861342
CASQ2,Calsequestrin-2,Diet and food preferences,X20639.Liking for chilli pepper,33170,-0.0301748119687183,0.036244532924849,-0.101214096501422,0.0408644725639857,0.405128877535932
CASQ2,Calsequestrin-2,Diet and food preferences,X20640.Liking for chips or french fries,33170,0.0406594154420364,0.0367007919756431,-0.0312741368302241,0.112592967714297,0.267950035990925
CASQ2,Calsequestrin-2,Diet and food preferences,X20641.Liking for cigarette smoking,33170,-0.00660684090198009,0.0574447807390533,-0.119198611150525,0.105984929346564,0.908438068674365
CASQ2,Calsequestrin-2,Diet and food preferences,X20642.Liking for cod,33170,0.0308701865132633,0.0373187745547411,-0.0422746116140293,0.104014984640556,0.408143472309402
CASQ2,Calsequestrin-2,Diet and food preferences,X20643.Liking for coffee with sugar,33170,0.0345112881655283,0.0390403726403098,-0.0420078422094789,0.111030418540535,0.376724610194149
CASQ2,Calsequestrin-2,Diet and food preferences,X20644.Liking for coffee without sugar,33170,0.0185954590320601,0.0371065397313381,-0.0541333588413626,0.0913242769054827,0.616286586605631
CASQ2,Calsequestrin-2,Diet and food preferences,X20645.Liking for coriander,33170,-0.0304160572880307,0.0361659373987626,-0.101301294589605,0.0404691800135441,0.400361748882313
CASQ2,Calsequestrin-2,Diet and food preferences,X20646.Liking for corn flakes,33170,0.0135924250390921,0.0351076405840273,-0.0552185505056013,0.0824034005837855,0.698643436979303
CASQ2,Calsequestrin-2,Diet and food preferences,X20647.Liking for cream,33170,0.045737549557914,0.0365767058603769,-0.0259527939284246,0.117427893044253,0.211164593502088
CASQ2,Calsequestrin-2,Diet and food preferences,X20648.Liking for croissant,33170,0.0119543802247327,0.0361281353518095,-0.058856765064814,0.0827655255142794,0.740736252225078
CASQ2,Calsequestrin-2,Diet and food preferences,X20649.Liking for cucumber,33170,0.0664830828698326,0.0357778713621945,-0.00364154500006862,0.136607710739734,0.0631696416122462
CASQ2,Calsequestrin-2,Diet and food preferences,X20650.Liking for curry,33170,0.0511111233354574,0.0376925339728462,-0.0227662432513211,0.124988489922236,0.175131688078902
CASQ2,Calsequestrin-2,Diet and food preferences,X20651.Liking for dairy products,33170,0.0835998079090133,0.0370929107333394,0.0108977028716681,0.156301912946359,0.0242322660064473
CASQ2,Calsequestrin-2,Diet and food preferences,X20652.Liking for dark chocolate,33170,0.0204556009409874,0.0358487272332357,-0.0498079044361546,0.0907191063181293,0.568278604059946
CASQ2,Calsequestrin-2,Diet and food preferences,X20653.Liking for diet fizzy drinks,33170,0.0045325742760774,0.0377805929130154,-0.0695173878334329,0.0785825363855877,0.904508737776566
CASQ2,Calsequestrin-2,Diet and food preferences,X20654.Liking for dried fruit,33170,0.060359875187101,0.0355900978484066,-0.00939671659577589,0.130116466969978,0.0899242987251219
CASQ2,Calsequestrin-2,Diet and food preferences,X20655.Liking for eggs,33170,0.0651173424863669,0.036678165590279,-0.00677186207057996,0.137006547043314,0.0758693830152884
CASQ2,Calsequestrin-2,Diet and food preferences,X20656.Liking for exercising alone,33170,0.0064993836640021,0.0361760076224625,-0.0644055912760245,0.0774043586040287,0.857423365108327
CASQ2,Calsequestrin-2,Diet and food preferences,X20657.Liking for exercising with others,33170,0.036374569505774,0.0355576854773085,-0.0333184940297506,0.106067633041299,0.306346987051996
CASQ2,Calsequestrin-2,Diet and food preferences,X20658.Liking for extra virgin olive oil,33170,0.0239384112150624,0.0364454060944616,-0.0474945847300824,0.0953714071602072,0.511306921819936
CASQ2,Calsequestrin-2,Diet and food preferences,X20659.Liking for fatty foods,33170,0.00261457134115704,0.0362298597622886,-0.0683959537929287,0.0736250964752428,0.942471194409658
CASQ2,Calsequestrin-2,Diet and food preferences,X20660.Liking for fresh tomatoes,33170,0.0275234279369456,0.0392050559068715,-0.0493184816405225,0.104365337514414,0.482673209306628
CASQ2,Calsequestrin-2,Diet and food preferences,X20661.Liking for fried chicken,33170,0.00695247653281992,0.0361379118710831,-0.0638778307345029,0.0777827838001428,0.847443013015761
CASQ2,Calsequestrin-2,Diet and food preferences,X20662.Liking for fried or battered fish,33170,0.0320308098930793,0.0363905413380256,-0.039294651129451,0.10335627091561,0.378775867225494
CASQ2,Calsequestrin-2,Diet and food preferences,X20663.Liking for fruit,33170,-0.0133130069761535,0.0395945560301461,-0.0909183367952399,0.0642923228429329,0.736702552353411
CASQ2,Calsequestrin-2,Diet and food preferences,X20664.Liking for garlic,33170,-0.0126707529047973,0.03683910332786,-0.0848753954274028,0.0595338896178083,0.730892820981154
CASQ2,Calsequestrin-2,Diet and food preferences,X20665.Liking for gherkins,33170,0.0291102096668097,0.0360026414581721,-0.0414549675912076,0.099675386924827,0.418790337538933
CASQ2,Calsequestrin-2,Diet and food preferences,X20666.Liking for globe artichoke,33170,-0.00171280003060189,0.0363779548997747,-0.0730135916341603,0.0695879915729565,0.962447719578062
CASQ2,Calsequestrin-2,Diet and food preferences,X20667.Liking for goat's cheese,33170,0.0905247509508618,0.0360469013750118,0.0198728242558388,0.161176677645885,0.0120453958545783
CASQ2,Calsequestrin-2,Diet and food preferences,X20668.Liking for going to a cafe,33170,0.0560425493172699,0.0360840461138132,-0.0146821810658039,0.126767279700344,0.12043050742193
CASQ2,Calsequestrin-2,Diet and food preferences,X20669.Liking for going to the gym,33170,0.0511748464509924,0.0356960796529056,-0.0187894696687026,0.121139162570687,0.151712485911581
CASQ2,Calsequestrin-2,Diet and food preferences,X20670.Liking for going to the pub,33170,0.04495302341833,0.036115046828435,-0.0258324683654027,0.115738515202063,0.213267047997523
CASQ2,Calsequestrin-2,Diet and food preferences,X20671.Liking for grapefruit,33170,0.0421214526692646,0.0360830299756832,-0.0286012860830744,0.112844191421604,0.24309978939627
CASQ2,Calsequestrin-2,Diet and food preferences,X20672.Liking for green olives,33170,0.00309904955095478,0.0358786008312832,-0.0672230080783603,0.0734211071802699,0.93116939463552
CASQ2,Calsequestrin-2,Diet and food preferences,X20673.Liking for haddock,33170,-0.0176480763526984,0.0366521841028587,-0.0894863571943014,0.0541902044889045,0.630171544061752
CASQ2,Calsequestrin-2,Diet and food preferences,X20674.Liking for ham,33170,0.0231817104079733,0.0367145096614117,-0.0487787285283936,0.0951421493443402,0.527791523456359
CASQ2,Calsequestrin-2,Diet and food preferences,X20675.Liking for hard cheese,33170,0.0522537925110005,0.0371785651372071,-0.0206161951579253,0.125123780179926,0.159911491602474
CASQ2,Calsequestrin-2,Diet and food preferences,X20676.Liking for herring,33170,-0.0236456250201848,0.0356881254429985,-0.0935943508884619,0.0463031008480922,0.507627006455647
CASQ2,Calsequestrin-2,Diet and food preferences,X20677.Liking for honey,33170,0.0379345789411903,0.0361534365979434,-0.0329261567907788,0.108795314673159,0.294082881825986
CASQ2,Calsequestrin-2,Diet and food preferences,X20678.Liking for horseradish or wasabi,33170,-0.000113609735110553,0.035415212448338,-0.0695274261338531,0.069300206663632,0.997440510577665
CASQ2,Calsequestrin-2,Diet and food preferences,X20679.Liking for ice cream,33170,0.0549467768977599,0.0365844766967316,-0.016758797427834,0.126652351223354,0.133152991510054
CASQ2,Calsequestrin-2,Diet and food preferences,X20680.Liking for jam,33170,0.107857508965695,0.035949408781889,0.0373966677531924,0.178318350178197,0.00270465681729378
CASQ2,Calsequestrin-2,Diet and food preferences,X20681.Liking for kiwi fruit,33170,-0.00227595552732343,0.0359609441518194,-0.0727594060648895,0.0682074950102426,0.949537218283191
CASQ2,Calsequestrin-2,Diet and food preferences,X20682.Liking for lager,33170,0.000632717486503521,0.0355705798879759,-0.0690856190939293,0.0703510540669363,0.985808628265469
CASQ2,Calsequestrin-2,Diet and food preferences,X20683.Liking for lamb,33170,-0.00413048997643347,0.0367265715129664,-0.0761145701418477,0.0678535901889807,0.910456367071634
CASQ2,Calsequestrin-2,Diet and food preferences,X20684.Liking for lemons,33170,0.0721932835184616,0.0365614063907716,0.000532926992549226,0.143853640044374,0.0483457927399921
CASQ2,Calsequestrin-2,Diet and food preferences,X20685.Liking for lentils or beans,33170,0.00130612053651714,0.0365348152524147,-0.0703021173582157,0.07291435843125,0.971482449505254
CASQ2,Calsequestrin-2,Diet and food preferences,X20686.Liking for liver,33170,-0.0136178384670291,0.0366139813387257,-0.0853812418909314,0.0581455649568732,0.709953433192348
CASQ2,Calsequestrin-2,Diet and food preferences,X20687.Liking for mackerel,33170,0.00598850577027188,0.0356015497299334,-0.0637905317003976,0.0757675432409413,0.866422414539132
CASQ2,Calsequestrin-2,Diet and food preferences,X20688.Liking for marzipan,33170,0.0460720358482113,0.0361709903127909,-0.0248231051648588,0.116967176861282,0.202791337569271
CASQ2,Calsequestrin-2,Diet and food preferences,X20689.Liking for mayonnaise,33170,0.0400600620407672,0.0361358690590344,-0.0307662413149402,0.110886365396475,0.267633382445857
CASQ2,Calsequestrin-2,Diet and food preferences,X20690.Liking for melon,33170,0.0491023526488377,0.037150961755666,-0.0237135323922676,0.121918237689943,0.186301234979087
CASQ2,Calsequestrin-2,Diet and food preferences,X20691.Liking for milk chocolate,33170,0.0736610864053811,0.0365829027587228,0.00195859699828453,0.145363575812478,0.044086747738719
CASQ2,Calsequestrin-2,Diet and food preferences,X20692.Liking for mushrooms,33170,0.0595812807700196,0.0374280479423854,-0.0137776931970557,0.132940254737095,0.111443732923074
CASQ2,Calsequestrin-2,Diet and food preferences,X20694.Liking for orange juice,33170,0.0706726995116624,0.0370699243184124,-0.00198435215242583,0.143329751175751,0.0566200375836349
CASQ2,Calsequestrin-2,Diet and food preferences,X20695.Liking for oranges,33170,0.0154210108094759,0.0366447523145065,-0.0564027037269568,0.0872447253459086,0.673892938200542
CASQ2,Calsequestrin-2,Diet and food preferences,X20696.Liking for pasta,33170,0.100499342762517,0.0369715114391621,0.0280351803417589,0.172963505183274,0.00657416363045562
CASQ2,Calsequestrin-2,Diet and food preferences,X20697.Liking for pears,33170,0.00561620181229697,0.0363886246940433,-0.065705502588028,0.0769379062126219,0.877345409721608
CASQ2,Calsequestrin-2,Diet and food preferences,X20698.Liking for pizza,33170,0.0401581238975627,0.0359709811660896,-0.030344999187973,0.110661246983098,0.264278359934294
CASQ2,Calsequestrin-2,Diet and food preferences,X20699.Liking for plain yogurt,33170,0.0680147421781263,0.0362402596235583,-0.00301616668404793,0.139045651040301,0.0605804879207246
CASQ2,Calsequestrin-2,Diet and food preferences,X20700.Liking for plums,33170,0.0580281138109442,0.036607292213228,-0.0137221789269828,0.129778406548871,0.112965853123654
CASQ2,Calsequestrin-2,Diet and food preferences,X20701.Liking for pollock,33170,-0.026420715218058,0.0366237323455324,-0.0982032306153015,0.0453618001791855,0.47067562293719
CASQ2,Calsequestrin-2,Diet and food preferences,X20702.Liking for pork chop,33170,0.0189882848677179,0.0363245315372596,-0.0522077969453108,0.0901843666807467,0.601167663799957
CASQ2,Calsequestrin-2,Diet and food preferences,X20703.Liking for porridge,33170,0.0303428093269337,0.0366758104435263,-0.0415417791423778,0.102227397796245,0.408074188314793
CASQ2,Calsequestrin-2,Diet and food preferences,X20704.Liking for potato crisps,33170,0.00286933601781942,0.0356655822628848,-0.0670352052174348,0.0727738772530736,0.935880202113302
CASQ2,Calsequestrin-2,Diet and food preferences,X20705.Liking for potatoes,33170,0.059011133224695,0.0370470356743027,-0.0136010566969383,0.131623323146328,0.111223204533336
CASQ2,Calsequestrin-2,Diet and food preferences,X20706.Liking for prawns,33170,-0.0365723544092311,0.0368469322237303,-0.108792341567742,0.0356476327492802,0.320956023801129
CASQ2,Calsequestrin-2,Diet and food preferences,X20707.Liking for raw carrots,33170,0.111804705528187,0.0363780068534526,0.0405038120954196,0.183105598960954,0.00212236602986867
CASQ2,Calsequestrin-2,Diet and food preferences,X20708.Liking for red meat,33170,0.0143143356744471,0.0366005174094824,-0.0574226784481384,0.0860513497970327,0.695734837317347
CASQ2,Calsequestrin-2,Diet and food preferences,X20709.Liking for red wine,33170,-0.0403855819170732,0.0361847552208979,-0.111307702150033,0.0305365383158867,0.26441080749758
CASQ2,Calsequestrin-2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,33170,0.0222127377828004,0.0373055064225319,-0.0509060548053621,0.0953315303709628,0.551571995489228
CASQ2,Calsequestrin-2,Diet and food preferences,X20711.Liking for roast chicken,33170,-0.0335725756637844,0.0380338246561924,-0.108118871989921,0.0409737206623526,0.377419509069179
CASQ2,Calsequestrin-2,Diet and food preferences,X20712.Liking for salad dressing,33170,0.0696137511021419,0.0356476016846445,-0.000255548199761396,0.139483050404045,0.0508695424194478
CASQ2,Calsequestrin-2,Diet and food preferences,X20713.Liking for salad leaves,33170,0.030623174188234,0.0374118831112331,-0.042704116709783,0.103950465086251,0.413069098035725
CASQ2,Calsequestrin-2,Diet and food preferences,X20714.Liking for salami,33170,0.0464584928047817,0.0362682332129422,-0.024627244292585,0.117544229902148,0.20023639279601
CASQ2,Calsequestrin-2,Diet and food preferences,X20715.Liking for salmon,33170,-0.0242033149646822,0.037855303283707,-0.0983997094007479,0.0499930794713834,0.522601963019201
CASQ2,Calsequestrin-2,Diet and food preferences,X20716.Liking for salty foods,33170,0.0588099317158224,0.0359034317679784,-0.0115607945494152,0.12918065798106,0.101454877886945
CASQ2,Calsequestrin-2,Diet and food preferences,X20717.Liking for salty pretzels,33170,0.00316726205417999,0.0351790395065072,-0.0657836553785741,0.0721181794869341,0.928263210032405
CASQ2,Calsequestrin-2,Diet and food preferences,X20718.Liking for sardines,33170,-0.0012223734558633,0.0356748004842361,-0.071144982404966,0.0687002354932394,0.972667096815782
CASQ2,Calsequestrin-2,Diet and food preferences,X20719.Liking for sausages (meat),33170,0.0443109296010278,0.0362291684971256,-0.0266982406533383,0.115320099855394,0.221332989950217
CASQ2,Calsequestrin-2,Diet and food preferences,X20720.Liking for savoury biscuits,33170,0.0311325758059668,0.0360623006550773,-0.0395495334779847,0.101814685089918,0.387994931789305
CASQ2,Calsequestrin-2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),33170,-0.0135228018963098,0.0364394745617072,-0.084944172037256,0.0578985682446364,0.710569195888074
CASQ2,Calsequestrin-2,Diet and food preferences,X20722.Liking for skimmed milk,33170,0.0450385721333119,0.0365221574024874,-0.0265448563755633,0.116622000642187,0.217537961973924
CASQ2,Calsequestrin-2,Diet and food preferences,X20723.Liking for smoked fish,33170,-0.0067458740506779,0.0365880837379367,-0.0784585181770339,0.0649667700756781,0.853724455630122
CASQ2,Calsequestrin-2,Diet and food preferences,X20724.Liking for soft cheese,33170,0.0668708563282316,0.0366991522470022,-0.00505948207589266,0.138801194732356,0.068466409300171
CASQ2,Calsequestrin-2,Diet and food preferences,X20725.Liking for soy sauce,33170,0.0124336297948684,0.0362837654424479,-0.0586825504723295,0.0835498100620663,0.731848840001819
CASQ2,Calsequestrin-2,Diet and food preferences,X20726.Liking for soya milk,33170,0.0514319138154632,0.0362979580782889,-0.019712084017983,0.122575911648909,0.156534889250046
CASQ2,Calsequestrin-2,Diet and food preferences,X20727.Liking for spicy foods,33170,-0.0410959711643124,0.0367719067495601,-0.11316890839345,0.0309769660648254,0.263770358550924
CASQ2,Calsequestrin-2,Diet and food preferences,X20728.Liking for spinach,33170,0.0315247709642412,0.0368491380434536,-0.0406995396009278,0.10374908152941,0.392291435452178
CASQ2,Calsequestrin-2,Diet and food preferences,X20729.Liking for spirits,33170,0.0517056812657447,0.0355460733576885,-0.0179646225153247,0.121375985046814,0.145810947538091
CASQ2,Calsequestrin-2,Diet and food preferences,X20730.Liking for strawberries,33170,0.0829990258026668,0.0401393534175324,0.00432589310430319,0.16167215850103,0.0386890675375785
CASQ2,Calsequestrin-2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,33170,-0.0329157313050939,0.0371162804036534,-0.105663640896254,0.0398321782860667,0.375194808454747
CASQ2,Calsequestrin-2,Diet and food preferences,X20732.Liking for sweet foods,33170,0.0654534727707416,0.0362744768567616,-0.00564450186851106,0.136551447409994,0.0712017928868359
CASQ2,Calsequestrin-2,Diet and food preferences,X20733.Liking for taking the stairs,33170,0.0544298452083186,0.0365960026523871,-0.0172983199903602,0.126158010406997,0.136965089373258
CASQ2,Calsequestrin-2,Diet and food preferences,X20734.Liking for tea with sugar,33170,0.0211495488166483,0.0435429198720104,-0.0641945741324921,0.106493671765789,0.627179068437122
CASQ2,Calsequestrin-2,Diet and food preferences,X20735.Liking for tea without sugar,33170,-0.00886947895794602,0.0375175651396741,-0.0824039066317074,0.0646649487158153,0.813120748484049
CASQ2,Calsequestrin-2,Diet and food preferences,X20736.Liking for tomato ketchup,33170,0.0651196897416169,0.0364833072395102,-0.00638759244782305,0.136626971931057,0.0743072963423403
CASQ2,Calsequestrin-2,Diet and food preferences,X20737.Liking for tinned tuna,33170,0.0184116850990246,0.0364511107816818,-0.0530324920330717,0.0898558622311209,0.613496156049073
CASQ2,Calsequestrin-2,Diet and food preferences,X20738.Liking for turnip (white),33170,0.011443503103414,0.0356391698467786,-0.058409269796272,0.0812962760031001,0.748146807393467
CASQ2,Calsequestrin-2,Diet and food preferences,X20739.Liking for vegetables,33170,0.00879959222835133,0.0400298224358052,-0.0696588597458269,0.0872580442025296,0.826011562460091
CASQ2,Calsequestrin-2,Diet and food preferences,X20740.Liking for vinegar,33170,0.0244799795628658,0.0362394288281177,-0.046549300940245,0.0955092600659766,0.499370644177639
CASQ2,Calsequestrin-2,Diet and food preferences,X20741.Liking for watching television,33170,-0.019869779928967,0.0366039436491061,-0.0916135094812148,0.0518739496232809,0.587258711508296
CASQ2,Calsequestrin-2,Diet and food preferences,X20742.Liking for whisky,33170,0.0503562269571115,0.0373214261380013,-0.0227937682733711,0.123506222187594,0.177287004157182
CASQ2,Calsequestrin-2,Diet and food preferences,X20743.Liking for white bread,33170,0.0522121799570093,0.0360195444759466,-0.0183861272158461,0.122810487129865,0.147217381860046
CASQ2,Calsequestrin-2,Diet and food preferences,X20744.Liking for white rice,33170,0.0821054850821865,0.036541081729696,0.0104849648919823,0.153726005272391,0.024667447919488
CASQ2,Calsequestrin-2,Diet and food preferences,X20745.Liking for white wine,33170,0.000260140303047087,0.0367110833256517,-0.0716935830152302,0.0722138636213244,0.994346268306529
CASQ2,Calsequestrin-2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,33170,-0.0389233956790487,0.0362169842486845,-0.10990868480647,0.032061893448373,0.282524543599963
CASQ2,Calsequestrin-2,Diet and food preferences,X20747.Liking for whole milk,33170,0.0389093590651091,0.0361853542564072,-0.032013935277449,0.109832653407667,0.282277634354277
CASQ2,Calsequestrin-2,Diet and food preferences,X20748.Liking for wholemeal bread,33170,0.0285589345340526,0.0386276225823765,-0.0471512057274053,0.10426907479551,0.459719412008808
CASQ2,Calsequestrin-2,Diet and food preferences,X20749.Liking for working up a sweat,33170,0.0220029009981155,0.0360416175323054,-0.048638669365203,0.0926444713614341,0.541554866292235
CASQ2,Calsequestrin-2,Physical measures,X21001.Body mass index (BMI),47564,-0.0032584810177269,0.0134791415634444,-0.0296775984820779,0.0231606364466241,0.808981807747937
CASQ2,Calsequestrin-2,Physical measures,X21002.Weight,47582,-0.00335872445065751,0.00794748146024133,-0.0189357881127305,0.0122183392114155,0.672580050439276
CASQ2,Calsequestrin-2,Physical measures,X21021.Pulse wave Arterial Stiffness index,31652,0.000232250904262617,0.0063800191991356,-0.0122725867260432,0.0127370885345684,0.970962071417405
CASQ2,Calsequestrin-2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,32706,0.024229063794162,0.0403748081592016,-0.0549055601978731,0.103363687786197,0.54845263906255
CASQ2,Calsequestrin-2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,32706,0.0110600008670896,0.0422978269956872,-0.0718437400444574,0.0939637417786366,0.793729097292925
CASQ2,Calsequestrin-2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,32707,0.000132060942567469,0.0418029879157727,-0.081801795372347,0.082065917257482,0.997479456885286
CASQ2,Calsequestrin-2,Health and medical history,X21040.Satisfaction with bowel habits,32679,0.0201243696697685,0.0392028140376622,-0.0567131458440495,0.0969618851835864,0.607726432158266
CASQ2,Calsequestrin-2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,32680,0.0171066031769651,0.0407320521863366,-0.0627282191082547,0.0969414254621848,0.674511095743418
CASQ2,Calsequestrin-2,Health and medical history,X21042.Greatest number of times bowels opened per day,32671,-0.0442608215191862,0.0415817934994223,-0.125761136778054,0.0372394937396815,0.287164068441542
CASQ2,Calsequestrin-2,Health and medical history,X21043.Least number of times bowels opened per week,32619,-0.0619945543164318,0.0413446101312137,-0.143029990173611,0.0190408815407471,0.133790600717855
CASQ2,Calsequestrin-2,Health and medical history,X21044.Average number of times bowels opened per day,32653,-0.0291539932522611,0.0462422089552679,-0.119788722804586,0.0614807363000639,0.52840822319122
CASQ2,Calsequestrin-2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,32711,0.0469055199864636,0.0417192188389353,-0.0348641489378497,0.128675188910777,0.260910150254719
CASQ2,Calsequestrin-2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,32705,0.0502649787772446,0.0423472754235207,-0.0327356810528559,0.133265638607345,0.235271025639574
CASQ2,Calsequestrin-2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,29045,-0.00743678723229593,0.0602910313809964,-0.125607208739049,0.110733634274457,0.901836194874463
CASQ2,Calsequestrin-2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,32708,0.012293372599978,0.0444451923878884,-0.0748192044802834,0.0994059496802393,0.782096622204505
CASQ2,Calsequestrin-2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,32706,-0.0335695076813243,0.0624667448201165,-0.156004327528753,0.0888653121661041,0.591006199848622
CASQ2,Calsequestrin-2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,32709,0.0613231454333535,0.0510478491765804,-0.0387306389527442,0.161376929819451,0.229671834721025
CASQ2,Calsequestrin-2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,32707,-0.123292785992017,0.113203549717848,-0.345171743438999,0.0985861714549653,0.276128553273985
CASQ2,Calsequestrin-2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,32710,-0.00180007082638121,0.0475852318694271,-0.0950671252904583,0.0914669836376959,0.969825393482332
CASQ2,Calsequestrin-2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,32709,0.0527715974351976,0.05062603439579,-0.0464554299805507,0.151998624850946,0.297263724827691
CASQ2,Calsequestrin-2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,32491,-0.0526773899198468,0.0436538216800052,-0.138238880412657,0.0328841005729635,0.22757792583958
CASQ2,Calsequestrin-2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,32709,0.0796018611410173,0.0441974352326227,-0.00702511191492317,0.166228834196958,0.0717287845186528
CASQ2,Calsequestrin-2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,32710,0.0858485635444837,0.062210055238225,-0.0360831447224373,0.207780271811405,0.167628005331765
CASQ2,Calsequestrin-2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,32709,0.0200518449752147,0.0418674135202016,-0.0620082855243805,0.10211197547481,0.63199542695914
CASQ2,Calsequestrin-2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,32708,0.000916305319857132,0.0419717570536845,-0.0813483385053645,0.0831809491450788,0.982582879940427
CASQ2,Calsequestrin-2,Working and living environment,X21100.Water hardness (USGS classification),47368,-0.0280420531607615,0.0246737781964829,-0.076402658425868,0.020318552104345,0.25575379418676
CASQ2,Calsequestrin-2,Lifestyle factors,X2139.Age first had sexual intercourse,45035,-0.0021909536188523,0.0036435736048738,-0.00933235788440495,0.00495045064670035,0.547633319312353
CASQ2,Calsequestrin-2,Health and medical history,X2149.Lifetime number of sexual partners,43339,-0.00909044674360661,0.0276444697961617,-0.0632736075440835,0.0450927140568702,0.742284556709295
CASQ2,Calsequestrin-2,Physical activities,X22032.IPAQ activity group,43330,0.0220469257017071,0.0270701626928196,-0.0310105931762194,0.0751044445796336,0.415404957810829
CASQ2,Calsequestrin-2,Physical activities,X22033.Summed days activity,43817,0.00239018120302294,0.00350920533541795,-0.00448786125439624,0.00926822366044211,0.495805040642956
CASQ2,Calsequestrin-2,Physical activities,X22034.Summed minutes activity,43330,-0.00106500179747772,0.00356231243342083,-0.00804713416698255,0.0059171305720271,0.764970999565013
CASQ2,Calsequestrin-2,Physical activities,X22037.MET minutes per week for walking,42671,-0.00011250578275569,0.00351399297493084,-0.00699993201362014,0.00677492044810876,0.974459226165676
CASQ2,Calsequestrin-2,Physical activities,X22038.MET minutes per week for moderate activity,43330,-0.00301863846429612,0.00365875264083682,-0.0101897936403363,0.00415251671174406,0.409355702486574
CASQ2,Calsequestrin-2,Physical activities,X22039.MET minutes per week for vigorous activity,43330,0.0504104280398764,0.0270727760753873,-0.00265221306788264,0.103473069147635,0.0626133604260345
CASQ2,Calsequestrin-2,Physical activities,X22040.Summed MET minutes per week for all activity,42671,0.0013489251228949,0.00361142937825858,-0.00572947645849191,0.00842732670428172,0.708768964326286
CASQ2,Calsequestrin-2,Eye measures,X2217.Age started wearing glasses or contact lenses,42837,0.00518393279601373,0.00420361265779166,-0.00305514801325793,0.0134230136052854,0.217513088253205
CASQ2,Calsequestrin-2,Working and living environment,X22501.Year ended full time education,29922,0.00576557918146836,0.0179383570135991,-0.029393600565186,0.0409247589281227,0.747910286192946
CASQ2,Calsequestrin-2,Lifestyle factors,X22506.Tobacco smoking,29883,-0.149658796906453,0.0995495989617968,-0.344776010871575,0.045458417058669,0.132798910469534
CASQ2,Calsequestrin-2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,45970,-0.0763756674227054,0.0571304107198628,-0.188351272433636,0.0355999375882256,0.181280343338276
CASQ2,Calsequestrin-2,Physical measures,X23098.Weight,47266,-0.00282329419445468,0.00800390662279606,-0.018510951175135,0.0128643627862256,0.724286903623876
CASQ2,Calsequestrin-2,Physical measures,X23099.Body fat percentage,47245,0.00283347559903807,0.0077560830253698,-0.0123684471306868,0.0180353983287629,0.714873607945352
CASQ2,Calsequestrin-2,Physical measures,X23100.Whole body fat mass,47213,0.0025508143622451,0.00738669737812457,-0.011927112498879,0.0170287412233693,0.729852849838416
CASQ2,Calsequestrin-2,Physical measures,X23101.Whole body fat-free mass,47262,-0.00727049663455456,0.00683419361306167,-0.0206655161161554,0.00612452284704631,0.287411627228002
CASQ2,Calsequestrin-2,Physical measures,X23102.Whole body water mass,47266,-0.00773163174534234,0.00683328446095041,-0.0211248692888051,0.00566160579812047,0.257870431556125
CASQ2,Calsequestrin-2,Physical measures,X23104.Body mass index (BMI),47266,-0.0024643946566804,0.0136272807249547,-0.0291738648775916,0.0242450755642308,0.856492587646761
CASQ2,Calsequestrin-2,Physical measures,X23105.Basal metabolic rate,47264,-0.00724214209741394,0.00732392965331077,-0.021597044217903,0.00711276002307517,0.322755160677952
CASQ2,Calsequestrin-2,Physical measures,X23106.Impedance of whole body,47263,0.00440018568974256,0.00561357155105821,-0.00660241455033152,0.0154027859298166,0.433137357383846
CASQ2,Calsequestrin-2,Physical measures,X23107.Impedance of leg (right),47263,0.00208733266674851,0.0046349712816159,-0.00699721104521865,0.0111718763787157,0.652466408461824
CASQ2,Calsequestrin-2,Physical measures,X23108.Impedance of leg (left),47262,0.00548238874336286,0.00458786793226353,-0.00350983240387366,0.0144746098905994,0.232108800499452
CASQ2,Calsequestrin-2,Physical measures,X23109.Impedance of arm (right),47257,0.0027192314585653,0.00562986500008321,-0.00831530394159778,0.0137537668587284,0.629099415128469
CASQ2,Calsequestrin-2,Physical measures,X23110.Impedance of arm (left),47261,0.00316563849687767,0.00563151010779082,-0.00787212131439234,0.0142033983081477,0.574033109827759
CASQ2,Calsequestrin-2,Physical measures,X23111.Leg fat percentage (right),47262,0.00201048044882756,0.00955695516775356,-0.0167211516799694,0.0207421125776245,0.833382060446084
CASQ2,Calsequestrin-2,Physical measures,X23112.Leg fat mass (right),47261,0.00374778064903956,0.00990673486379817,-0.0156694196840048,0.023164980982084,0.705206464684785
CASQ2,Calsequestrin-2,Physical measures,X23113.Leg fat-free mass (right),47261,-0.0101126968192084,0.0073501207010026,-0.0245189333931735,0.00429353975475668,0.168879844394751
CASQ2,Calsequestrin-2,Physical measures,X23114.Leg predicted mass (right),47260,-0.0103212454955074,0.00738397823055728,-0.0247938428273996,0.00415135183638491,0.162189609394103
CASQ2,Calsequestrin-2,Physical measures,X23115.Leg fat percentage (left),47259,0.00660498302920889,0.00987002014924276,-0.0127402564633069,0.0259502225217247,0.503376735221602
CASQ2,Calsequestrin-2,Physical measures,X23116.Leg fat mass (left),47259,0.0041541958284287,0.01028511636567,-0.0160046322482846,0.024313023905142,0.686287278543526
CASQ2,Calsequestrin-2,Physical measures,X23117.Leg fat-free mass (left),47257,-0.0129378956748494,0.0076231198000621,-0.0278792104829711,0.00200341913327231,0.0896737231880388
CASQ2,Calsequestrin-2,Physical measures,X23118.Leg predicted mass (left),47256,-0.0135077834061809,0.00765367674543024,-0.0285089898272242,0.00149342301486237,0.0775978063527079
CASQ2,Calsequestrin-2,Physical measures,X23119.Arm fat percentage (right),47256,0.0118347220715353,0.00855687899135634,-0.00493676075152317,0.0286062048945937,0.166658054866022
CASQ2,Calsequestrin-2,Physical measures,X23120.Arm fat mass (right),47254,0.00404565389655917,0.0083582056439047,-0.012336429165494,0.0204277369586124,0.628366424664009
CASQ2,Calsequestrin-2,Physical measures,X23121.Arm fat-free mass (right),47254,-0.00623899114896831,0.00684156315831058,-0.019648454939257,0.00717047264132044,0.361817699610193
CASQ2,Calsequestrin-2,Physical measures,X23122.Arm predicted mass (right),47253,-0.00451318960279806,0.00684345994947902,-0.0179263711037769,0.00889999189818081,0.509588013983494
CASQ2,Calsequestrin-2,Physical measures,X23123.Arm fat percentage (left),47250,0.0121348800200314,0.00876834722902476,-0.00505108054885717,0.0293208405889199,0.16638955921845
CASQ2,Calsequestrin-2,Physical measures,X23124.Arm fat mass (left),47250,0.00546979933303954,0.00831847995135328,-0.0108344213716129,0.021774020037692,0.510835128655442
CASQ2,Calsequestrin-2,Physical measures,X23125.Arm fat-free mass (left),47246,-0.00929480875099564,0.00694398380809197,-0.0229050170148559,0.00431539951286461,0.180733076086398
CASQ2,Calsequestrin-2,Physical measures,X23126.Arm predicted mass (left),47245,-0.00780031958388244,0.0069797778709995,-0.0214806842110415,0.00588004504327658,0.26376650121583
CASQ2,Calsequestrin-2,Physical measures,X23127.Trunk fat percentage,47243,-0.00034264697436239,0.00554379228758346,-0.011208479858026,0.0105231859093012,0.950716798002136
CASQ2,Calsequestrin-2,Physical measures,X23128.Trunk fat mass,47239,0.00206334466890239,0.0060485098434435,-0.00979173462424686,0.0139184239620516,0.733006728862296
CASQ2,Calsequestrin-2,Physical measures,X23129.Trunk fat-free mass,47234,-0.00307707562693654,0.00621522612180474,-0.0152589188256738,0.00910476757180076,0.620543594018448
CASQ2,Calsequestrin-2,Physical measures,X23130.Trunk predicted mass,47232,-0.00300363478812733,0.00620463161106576,-0.0151647127458162,0.00915744316956156,0.628322568203574
CASQ2,Calsequestrin-2,NMR metabolomics,X23400.Total Cholesterol,37021,-0.00386895038001058,0.00477710582168281,-0.0132320777905089,0.00549417703048772,0.418015618405791
CASQ2,Calsequestrin-2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,37021,-0.00153422452132316,0.00463082554845125,-0.0106106425962876,0.0075421935536413,0.740417944279272
CASQ2,Calsequestrin-2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",37021,0.00112512228347004,0.00464994313710398,-0.00798876626525376,0.0102390108321938,0.808811254634986
CASQ2,Calsequestrin-2,NMR metabolomics,X23403.VLDL Cholesterol,37021,0.00272981026407668,0.00457231857261063,-0.00623193413824016,0.0116915546663935,0.550497781312889
CASQ2,Calsequestrin-2,NMR metabolomics,X23404.Clinical LDL Cholesterol,37021,-0.00263495291889624,0.00462469590368102,-0.011699356890111,0.00642945105231856,0.568852240580107
CASQ2,Calsequestrin-2,NMR metabolomics,X23405.LDL Cholesterol,37021,-0.00365748987918737,0.00458877690878293,-0.0126514926204019,0.00533651286202718,0.425435708092745
CASQ2,Calsequestrin-2,NMR metabolomics,X23406.HDL Cholesterol,37021,-0.00914830663601619,0.00522333560191003,-0.0193860444157599,0.00108943114372748,0.0798951627002827
CASQ2,Calsequestrin-2,NMR metabolomics,X23407.Total Triglycerides,37021,0.00411885758790402,0.004686094060201,-0.00506588677008994,0.013303601945898,0.379442673186024
CASQ2,Calsequestrin-2,NMR metabolomics,X23408.Triglycerides in VLDL,37021,0.0041035024972932,0.00476082644531559,-0.00522771733552536,0.0134347223301118,0.388741354864765
CASQ2,Calsequestrin-2,NMR metabolomics,X23409.Triglycerides in LDL,37021,0.000444049108071255,0.00448641603627869,-0.00834932632303498,0.0092374245391775,0.921158550952659
CASQ2,Calsequestrin-2,NMR metabolomics,X23410.Triglycerides in HDL,37021,0.00297349903606494,0.00442273095568816,-0.00569505363708385,0.0116420517092137,0.501390570814797
CASQ2,Calsequestrin-2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,37021,-0.00369695459185225,0.0047276387606575,-0.012963126562741,0.00556921737903646,0.434235965725203
CASQ2,Calsequestrin-2,NMR metabolomics,X23412.Phospholipids in VLDL,37021,0.00339626444978349,0.00461832979376292,-0.00565566194599183,0.0124481908455588,0.462116313909476
CASQ2,Calsequestrin-2,NMR metabolomics,X23413.Phospholipids in LDL,37021,-0.00290322935185076,0.00459131099787148,-0.0119021989076789,0.00609574020397734,0.52718144226944
CASQ2,Calsequestrin-2,NMR metabolomics,X23414.Phospholipids in HDL,37021,-0.00596050458692659,0.00489732778350697,-0.0155592670426002,0.00363825786874707,0.223590562233122
CASQ2,Calsequestrin-2,NMR metabolomics,X23415.Total Esterified Cholesterol,37021,-0.00438867144527514,0.00479521957314687,-0.013787301808643,0.00500995891809273,0.36009394525319
CASQ2,Calsequestrin-2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,37021,0.00256918431492468,0.00457369505427154,-0.00639525799144753,0.0115336266212969,0.574309170398683
CASQ2,Calsequestrin-2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,37021,-0.00360563010848964,0.00457134933200625,-0.0125654747992219,0.0053542145822426,0.430275117549793
CASQ2,Calsequestrin-2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,37021,-0.009510714548546,0.00521239677436704,-0.0197270122263054,0.000705583129213403,0.0680789910733266
CASQ2,Calsequestrin-2,NMR metabolomics,X23419.Total Free Cholesterol,37021,-0.00243450218321605,0.00472721711155273,-0.0116998477218594,0.0068308433554273,0.606563831525657
CASQ2,Calsequestrin-2,NMR metabolomics,X23420.Free Cholesterol in VLDL,37021,0.00292832491556701,0.00459564640694292,-0.00607914204204111,0.0119357918731751,0.524008633890163
CASQ2,Calsequestrin-2,NMR metabolomics,X23421.Free Cholesterol in LDL,37021,-0.00365695297463061,0.00464337752971454,-0.0127579729328711,0.00544406698360988,0.430966466886936
CASQ2,Calsequestrin-2,NMR metabolomics,X23422.Free Cholesterol in HDL,37021,-0.00732075669138034,0.00518142084481954,-0.0174763415472266,0.00283482816446595,0.157712909736118
CASQ2,Calsequestrin-2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,37021,-0.00217553788217604,0.0046076213908136,-0.0112064758081707,0.00685540004381861,0.636819895331228
CASQ2,Calsequestrin-2,NMR metabolomics,X23424.Total Lipids in VLDL,37021,0.00366075400833774,0.00466023489648903,-0.00547330638878075,0.0127948144054562,0.432157068059222
CASQ2,Calsequestrin-2,NMR metabolomics,X23425.Total Lipids in LDL,37021,-0.00338827884525311,0.00458397450825999,-0.0123728688814427,0.00559631119093647,0.459824585624927
CASQ2,Calsequestrin-2,NMR metabolomics,X23426.Total Lipids in HDL,37021,-0.00713739501302593,0.0050085649287143,-0.016954182273306,0.0026793922472541,0.154169949481965
CASQ2,Calsequestrin-2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,37021,-0.00828930463005289,0.00473549188218696,-0.0175708687191393,0.000992259459033551,0.0800617053046048
CASQ2,Calsequestrin-2,NMR metabolomics,X23428.Concentration of VLDL Particles,37021,0.00245715996472273,0.00456213741765167,-0.00648462937387454,0.01139894930332,0.590173093267967
CASQ2,Calsequestrin-2,NMR metabolomics,X23429.Concentration of LDL Particles,37021,-0.00126698079747768,0.00458669638800026,-0.0102569057179582,0.00772294412300283,0.782376146732876
CASQ2,Calsequestrin-2,NMR metabolomics,X23430.Concentration of HDL Particles,37021,-0.00849368775454324,0.00472965001070845,-0.0177638017755318,0.000776426266445316,0.0725431288177906
CASQ2,Calsequestrin-2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,37021,0.00364045199148018,0.00499144010834786,-0.00614277062088162,0.013423674603842,0.465807294004146
CASQ2,Calsequestrin-2,NMR metabolomics,X23432.Average Diameter for LDL Particles,37021,-0.00242614614642452,0.0045699424507714,-0.0113832333499365,0.00653094105708742,0.595502540878731
CASQ2,Calsequestrin-2,NMR metabolomics,X23433.Average Diameter for HDL Particles,37021,-0.00343103179616871,0.00530138817840764,-0.0138217526258477,0.00695968903351027,0.51751705000826
CASQ2,Calsequestrin-2,NMR metabolomics,X23434.Phosphoglycerides,37009,-0.00394925822765959,0.00467088154529059,-0.0131041860564292,0.00520566960110997,0.397843786296814
CASQ2,Calsequestrin-2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,37009,0.00651510871501896,0.00501406423599053,-0.00331245718752247,0.0163426746175604,0.193840853050037
CASQ2,Calsequestrin-2,NMR metabolomics,X23436.Total Cholines,37009,-0.00469975972069135,0.00475322222344305,-0.0140160752786397,0.00461655583725703,0.322802508678666
CASQ2,Calsequestrin-2,NMR metabolomics,X23437.Phosphatidylcholines,37009,-0.0042437907666453,0.00473825629915808,-0.0135307731129951,0.00504319157970455,0.370459329950164
CASQ2,Calsequestrin-2,NMR metabolomics,X23438.Sphingomyelins,37008,-0.00576415580252018,0.00491301848232504,-0.0153936720278772,0.00386536042283689,0.240720339776166
CASQ2,Calsequestrin-2,NMR metabolomics,X23439.Apolipoprotein B,37021,-0.000468710126812072,0.00460385507020759,-0.00949226606441895,0.00855484581079481,0.918910479994833
CASQ2,Calsequestrin-2,NMR metabolomics,X23440.Apolipoprotein A1,37021,-0.00753819458984468,0.00486847929550674,-0.0170804140090379,0.00200402482934852,0.121557911747309
CASQ2,Calsequestrin-2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,37021,0.00366558292270115,0.00458282433800516,-0.00531675277978897,0.0126479186251913,0.423810770877323
CASQ2,Calsequestrin-2,NMR metabolomics,X23442.Total Fatty Acids,37009,-0.000471787420489793,0.00448572275310641,-0.00926380401657835,0.00832022917559877,0.916238281412244
CASQ2,Calsequestrin-2,NMR metabolomics,X23443.Degree of Unsaturation,37009,-0.00409436590727451,0.00494755765253978,-0.0137915789062525,0.00560284709170347,0.407938744383282
CASQ2,Calsequestrin-2,NMR metabolomics,X23444.Omega-3 Fatty Acids,37009,-0.00235761049258535,0.00456166545814052,-0.0112984747905408,0.00658325380537007,0.60528277332616
CASQ2,Calsequestrin-2,NMR metabolomics,X23445.Omega-6 Fatty Acids,37009,-0.00236120067197887,0.00455593402314757,-0.0112908313573481,0.00656843001339037,0.604279119809311
CASQ2,Calsequestrin-2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,37009,-0.00246115087913603,0.00456084091316879,-0.0114003990689469,0.0064780973106748,0.58946373577644
CASQ2,Calsequestrin-2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,37009,0.000980310659381702,0.00455740386517116,-0.00795220091635378,0.00991282223511718,0.829690450931087
CASQ2,Calsequestrin-2,NMR metabolomics,X23448.Saturated Fatty Acids,37009,0.000235919573574668,0.0045051883652099,-0.00859424962223674,0.00906608876938608,0.958237704903453
CASQ2,Calsequestrin-2,NMR metabolomics,X23449.Linoleic Acid,37009,-0.00143508177303525,0.00458817270299862,-0.0104279002709126,0.00755773672484205,0.754453911718502
CASQ2,Calsequestrin-2,NMR metabolomics,X23450.Docosahexaenoic Acid,37009,-0.00304541149198144,0.00476258332820178,-0.0123800748152569,0.00628925183129404,0.522544431660381
CASQ2,Calsequestrin-2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,37009,-0.00245515355801205,0.00460961263702942,-0.0114899943265897,0.00657968721056561,0.594308407261876
CASQ2,Calsequestrin-2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,37009,-0.00336637650923542,0.00468887777625319,-0.0125565769506917,0.00582382393222083,0.472801304695382
CASQ2,Calsequestrin-2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,37009,-0.00432912792116226,0.00486686834770185,-0.0138681898826579,0.00520993404033337,0.373745340090937
CASQ2,Calsequestrin-2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,37009,0.00384302271816326,0.00497772213819708,-0.00591331267270301,0.0135993581090295,0.440101980332698
CASQ2,Calsequestrin-2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,37009,0.00165018032688369,0.00447898922482412,-0.00712863855377158,0.010428999207539,0.712560838513802
CASQ2,Calsequestrin-2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,37009,-0.00177361723447764,0.00479499846653746,-0.0111718142288911,0.00762457975993578,0.711471147676209
CASQ2,Calsequestrin-2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,37009,-0.00232952472126804,0.00480771965899755,-0.0117526552529032,0.00709360581036716,0.628011900040875
CASQ2,Calsequestrin-2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,37009,-0.00418327687805898,0.00497111547803073,-0.0139266632149992,0.00556010945888126,0.400073816186393
CASQ2,Calsequestrin-2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,37007,0.00177851130386574,0.00457463953934139,-0.00718778219324339,0.0107448048009749,0.697447951132016
CASQ2,Calsequestrin-2,NMR metabolomics,X23460.Alanine,37017,0.00239619340006964,0.00445536166368369,-0.00633631546075039,0.0111287022608897,0.590708747550497
CASQ2,Calsequestrin-2,NMR metabolomics,X23461.Glutamine,36984,-0.00930867467053793,0.0044180668865846,-0.0179680857682437,-0.000649263572832119,0.0351402779052925
CASQ2,Calsequestrin-2,NMR metabolomics,X23462.Glycine,37005,-0.00557075660319906,0.00461665696707011,-0.0146194042586565,0.00347789105225835,0.227583046345015
CASQ2,Calsequestrin-2,NMR metabolomics,X23463.Histidine,37007,-0.00226276763222897,0.00438524558309267,-0.0108578489750906,0.00633231371063265,0.605866127015548
CASQ2,Calsequestrin-2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),37010,0.00308492547224593,0.00468424025026968,-0.00609618541828265,0.0122660363627745,0.510179983927697
CASQ2,Calsequestrin-2,NMR metabolomics,X23465.Isoleucine,37019,0.00209175943595091,0.00456421932404768,-0.00685411043918255,0.0110376293110844,0.646747998824097
CASQ2,Calsequestrin-2,NMR metabolomics,X23466.Leucine,37020,0.0033505062962275,0.00470374635099485,-0.00586883655172239,0.0125698491441774,0.47628799680783
CASQ2,Calsequestrin-2,NMR metabolomics,X23467.Valine,37010,0.00314141295023691,0.00466831823743841,-0.00600849079514237,0.0122913166956162,0.501008889216954
CASQ2,Calsequestrin-2,NMR metabolomics,X23468.Phenylalanine,37017,0.00407256417840327,0.00441230234093811,-0.00457554840983543,0.012720676766642,0.356023054122119
CASQ2,Calsequestrin-2,NMR metabolomics,X23469.Tyrosine,37007,-0.000958329603828932,0.00453723614314276,-0.00985131244438874,0.00793465323673087,0.832723249351899
CASQ2,Calsequestrin-2,NMR metabolomics,X23470.Glucose,37001,-0.0102519114567211,0.00453385500619146,-0.0191382672688563,-0.0013655556445858,0.0237637199493889
CASQ2,Calsequestrin-2,NMR metabolomics,X23471.Lactate,37000,0.00183363793692963,0.00445440080730276,-0.00689698764538377,0.010564263519243,0.680605350786811
CASQ2,Calsequestrin-2,NMR metabolomics,X23472.Pyruvate,36981,-0.00144998220432733,0.00438753214129433,-0.0100495452012642,0.00714958079260956,0.741044200391985
CASQ2,Calsequestrin-2,NMR metabolomics,X23473.Citrate,37020,-0.00232543693689741,0.0044964531420328,-0.0111384850952817,0.00648761122148688,0.605045211329938
CASQ2,Calsequestrin-2,NMR metabolomics,X23474.3-Hydroxybutyrate,36813,0.000497754659567595,0.00439071034861457,-0.00810803762371697,0.00910354694285216,0.909742622067838
CASQ2,Calsequestrin-2,NMR metabolomics,X23475.Acetate,37011,-0.00133403347321864,0.00439515645875925,-0.00994854013238678,0.0072804731859495,0.76149570774417
CASQ2,Calsequestrin-2,NMR metabolomics,X23476.Acetoacetate,37021,-0.00174799946117941,0.00436483469700083,-0.010303075467301,0.00680707654494223,0.688814495164152
CASQ2,Calsequestrin-2,NMR metabolomics,X23477.Acetone,37021,0.00113440217499377,0.00438328621379162,-0.0074568388040378,0.00972564315402534,0.795792249211411
CASQ2,Calsequestrin-2,NMR metabolomics,X23478.Creatinine,36688,-0.00278645498923836,0.00554230580326807,-0.0136493743636438,0.00807646438516706,0.615140975218184
CASQ2,Calsequestrin-2,NMR metabolomics,X23479.Albumin,37020,-0.0058040508901935,0.00450022699559035,-0.0146244958015506,0.0030163940211636,0.1971691582026
CASQ2,Calsequestrin-2,NMR metabolomics,X23480.Glycoprotein Acetyls,37021,0.00359250602958822,0.00472079094905718,-0.00566024423056385,0.0128452562897403,0.446672710919655
CASQ2,Calsequestrin-2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,37021,0.00517258093825465,0.00473843238419566,-0.00411474653476884,0.0144599084112781,0.275018903112033
CASQ2,Calsequestrin-2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,37021,0.00602853133152885,0.00476590390432571,-0.00331264032094954,0.0153697029840072,0.205919081585549
CASQ2,Calsequestrin-2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,37021,0.00532838200778397,0.00476597379000818,-0.00401292662063206,0.0146696906362,0.263585311303102
CASQ2,Calsequestrin-2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,37021,0.00606166477855803,0.00472974730956525,-0.00320863994818987,0.0153319695053059,0.200004047640356
CASQ2,Calsequestrin-2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,37021,0.00565588002496738,0.00474029866266242,-0.00363510535385096,0.0149468654037857,0.232832745879036
CASQ2,Calsequestrin-2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,37021,0.00621182932391882,0.00469500206276629,-0.00299037471910311,0.0154140333669408,0.185834169234812
CASQ2,Calsequestrin-2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,37021,0.0064119185990149,0.00475922803559355,-0.00291616835074845,0.0157400055487782,0.177919634288983
CASQ2,Calsequestrin-2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,37021,0.00454642515749331,0.00481137571084644,-0.00488387123576571,0.0139767215507523,0.344710697712663
CASQ2,Calsequestrin-2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,37021,0.00401370523407391,0.00481788653733194,-0.0054293523790967,0.0134567628472445,0.404812351904376
CASQ2,Calsequestrin-2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,37021,0.00478973326212394,0.00478928821272403,-0.00459727163481516,0.014176738159063,0.317283926004155
CASQ2,Calsequestrin-2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,37021,0.00432708164838866,0.0047200958121405,-0.00492430614340672,0.013578469440184,0.359297806168211
CASQ2,Calsequestrin-2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,37021,0.00367798037710959,0.00467808813382135,-0.00549107236518026,0.0128470331193994,0.431756031082511
CASQ2,Calsequestrin-2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,37021,0.00503121175055967,0.00475175151839553,-0.00428222122549556,0.0143446447266149,0.289704818293389
CASQ2,Calsequestrin-2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,37021,0.00346959660632296,0.00486425717580271,-0.00606434745825035,0.0130035406708963,0.475682709942006
CASQ2,Calsequestrin-2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,37021,0.00371160008609389,0.00476120210832401,-0.00562035604622116,0.0130435562184089,0.435669197586678
CASQ2,Calsequestrin-2,NMR metabolomics,X23496.Total Lipids in Large VLDL,37021,0.00365756968080476,0.00476482770660676,-0.00568149262414449,0.012996631985754,0.442727666227031
CASQ2,Calsequestrin-2,NMR metabolomics,X23497.Phospholipids in Large VLDL,37021,0.0041682314045115,0.00479132417855732,-0.00522276398546084,0.0135592267944838,0.384341435367006
CASQ2,Calsequestrin-2,NMR metabolomics,X23498.Cholesterol in Large VLDL,37021,0.00366231138127186,0.00468433100592426,-0.00551897739033969,0.0128436001528834,0.434333462001517
CASQ2,Calsequestrin-2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,37021,0.00353312354738454,0.0046080369808728,-0.00549862893512616,0.0125648760298952,0.443255382982408
CASQ2,Calsequestrin-2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,37021,0.00372584609861567,0.00476922525949395,-0.00562183540999247,0.0130735276072238,0.434683226442121
CASQ2,Calsequestrin-2,NMR metabolomics,X23501.Triglycerides in Large VLDL,37021,0.00299756268689008,0.00479325033409538,-0.00639720796793687,0.012392333341717,0.531738032618988
CASQ2,Calsequestrin-2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,37021,0.000904816824881806,0.00456345822476214,-0.00803956129565198,0.0098491949454156,0.842833462296367
CASQ2,Calsequestrin-2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,37021,0.00116522742445657,0.00458025767352861,-0.00781207761565951,0.0101425324645727,0.799188860523241
CASQ2,Calsequestrin-2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,37021,0.000971332121606505,0.00456515602985317,-0.0079763736969057,0.00991903794011871,0.831508998010598
CASQ2,Calsequestrin-2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,37021,-0.00019225261832763,0.00461219421956704,-0.00923215328867902,0.00884764805202376,0.966751601803237
CASQ2,Calsequestrin-2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,37021,-0.00044197495153736,0.0046634531673853,-0.00958234315961255,0.00869839325653783,0.924495638448351
CASQ2,Calsequestrin-2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,37021,0.000582890340933453,0.004564587499988,-0.00836370115904302,0.00952948184090993,0.898389638454373
CASQ2,Calsequestrin-2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,37021,0.00209225000890834,0.00469123636713306,-0.00710257327067245,0.0112870732884891,0.655610959086806
CASQ2,Calsequestrin-2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,37021,0.00163317814712856,0.00457811723832893,-0.00733993163999613,0.0106062879342533,0.721295348608364
CASQ2,Calsequestrin-2,NMR metabolomics,X23510.Total Lipids in Small VLDL,37021,0.00132092870782532,0.00456871718388605,-0.00763375697259134,0.010275614388242,0.772490552901095
CASQ2,Calsequestrin-2,NMR metabolomics,X23511.Phospholipids in Small VLDL,37021,0.000480199615403641,0.00454041293042411,-0.00841900972822761,0.0093794089590349,0.915773417140052
CASQ2,Calsequestrin-2,NMR metabolomics,X23512.Cholesterol in Small VLDL,37021,0.000995635066830867,0.00454915843372505,-0.00792071546327023,0.00991198559693196,0.826761429531833
CASQ2,Calsequestrin-2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,37021,0.00161082616152196,0.00455558361162968,-0.00731811771727222,0.0105397700403161,0.723648978460937
CASQ2,Calsequestrin-2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,37021,-0.000183135959651417,0.00455369944777873,-0.00910838687729773,0.0087421149579949,0.967920764523095
CASQ2,Calsequestrin-2,NMR metabolomics,X23515.Triglycerides in Small VLDL,37021,0.00151534539778581,0.00462082529485917,-0.00754147218013815,0.0105721629757098,0.742963562722314
CASQ2,Calsequestrin-2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,37021,0.0028735456715003,0.00458528082929739,-0.00611360475392257,0.0118606960969232,0.530873897876486
CASQ2,Calsequestrin-2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,37021,0.0032623388778921,0.00456899378267279,-0.00569288893614658,0.0122175666919308,0.475229377904064
CASQ2,Calsequestrin-2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,37021,0.00392817204227468,0.00453794328518437,-0.00496619679668668,0.012822540881236,0.386709820485663
CASQ2,Calsequestrin-2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,37021,0.00280361642278433,0.00473972248197942,-0.00648623964189533,0.012093472487464,0.554185640846688
CASQ2,Calsequestrin-2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,37021,0.00255111488862355,0.00480208491032982,-0.0068609715356229,0.01196320131287,0.595253463657935
CASQ2,Calsequestrin-2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,37021,0.00341415073279965,0.00460229310350431,-0.00560634375006879,0.0124346452156681,0.458199413616381
CASQ2,Calsequestrin-2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,37021,0.00163709867978314,0.00449304960917869,-0.0071692785542071,0.0104434759137734,0.715593206013181
CASQ2,Calsequestrin-2,NMR metabolomics,X23523.Concentration of IDL Particles,37021,0.00105872092326829,0.00471287654941446,-0.00817851711358405,0.0102959589601206,0.822259475050453
CASQ2,Calsequestrin-2,NMR metabolomics,X23524.Total Lipids in IDL,37021,-0.000672731900580519,0.0048261220232814,-0.0101319310662121,0.00878646726505102,0.889141036771032
CASQ2,Calsequestrin-2,NMR metabolomics,X23525.Phospholipids in IDL,37021,-0.000891391993525314,0.00482111658463839,-0.0103407804994166,0.00855799651236593,0.853315601429009
CASQ2,Calsequestrin-2,NMR metabolomics,X23526.Cholesterol in IDL,37021,-0.000822290739880431,0.00485484201661885,-0.0103377810924534,0.00869319961269252,0.865503986111371
CASQ2,Calsequestrin-2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,37021,-0.000606539976748406,0.00485004214318994,-0.0101126225774007,0.00889954262390388,0.900478987357824
CASQ2,Calsequestrin-2,NMR metabolomics,X23528.Free Cholesterol in IDL,37021,-0.00129569724022088,0.00484598441564855,-0.010793826694892,0.00820243221445028,0.789184292986677
CASQ2,Calsequestrin-2,NMR metabolomics,X23529.Triglycerides in IDL,37021,0.00142934842668764,0.00444006399037593,-0.00727317699444917,0.0101318738478245,0.74751789756094
CASQ2,Calsequestrin-2,NMR metabolomics,X23530.Concentration of Large LDL Particles,37021,-0.00174247517509539,0.00459658731901812,-0.0107517863203709,0.00726683597018012,0.704634435003771
CASQ2,Calsequestrin-2,NMR metabolomics,X23531.Total Lipids in Large LDL,37021,-0.00378271483322465,0.00462253002384633,-0.0128428736799635,0.00527744401351417,0.413188555633824
CASQ2,Calsequestrin-2,NMR metabolomics,X23532.Phospholipids in Large LDL,37021,-0.00276727356635156,0.00463443750303121,-0.0118507710722927,0.00631622393958961,0.550443552737726
CASQ2,Calsequestrin-2,NMR metabolomics,X23533.Cholesterol in Large LDL,37021,-0.00419290270524392,0.00463015712124046,-0.0132680106628752,0.00488220525238738,0.36518335065845
CASQ2,Calsequestrin-2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,37021,-0.00444069830180062,0.00460403860608092,-0.0134646139697192,0.00458321736611799,0.334801812383579
CASQ2,Calsequestrin-2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,37021,-0.00343208244600953,0.00470589942677057,-0.0126556453224799,0.0057914804304608,0.465822054728019
CASQ2,Calsequestrin-2,NMR metabolomics,X23536.Triglycerides in Large LDL,37021,0.000349291759203529,0.00446206418823605,-0.00839635404973912,0.00909493756814618,0.937606271328845
CASQ2,Calsequestrin-2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,37021,-0.000225532657918596,0.00455898470107333,-0.00916114267202233,0.00871007735618514,0.960545550239334
CASQ2,Calsequestrin-2,NMR metabolomics,X23538.Total Lipids in Medium LDL,37021,-0.00275337589604534,0.00454439032061218,-0.0116603809244452,0.00615362913235453,0.544601866546626
CASQ2,Calsequestrin-2,NMR metabolomics,X23539.Phospholipids in Medium LDL,37021,-0.00301713121980752,0.00453724593620207,-0.0119101332547636,0.00587587081514853,0.506081503742704
CASQ2,Calsequestrin-2,NMR metabolomics,X23540.Cholesterol in Medium LDL,37021,-0.0027363658944732,0.00454482340504632,-0.011644219768364,0.00617148797941759,0.547128531995441
CASQ2,Calsequestrin-2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,37021,-0.00210151275556608,0.00455039262830881,-0.0110202823070513,0.00681725679591919,0.644210092193765
CASQ2,Calsequestrin-2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,37021,-0.00407854294678276,0.00454783365751056,-0.0129922969155035,0.00483521102193794,0.36983668594635
CASQ2,Calsequestrin-2,NMR metabolomics,X23543.Triglycerides in Medium LDL,37021,-0.000104603025131306,0.00452213126809239,-0.00896798031059238,0.00875877426032977,0.981545845125123
CASQ2,Calsequestrin-2,NMR metabolomics,X23544.Concentration of Small LDL Particles,37021,-0.00113590087398883,0.00458221592319403,-0.0101170440834491,0.00784524233547147,0.804220789484711
CASQ2,Calsequestrin-2,NMR metabolomics,X23545.Total Lipids in Small LDL,37021,-0.00241414455948171,0.00457681664906972,-0.0113847051916584,0.00655641607269494,0.597874454743317
CASQ2,Calsequestrin-2,NMR metabolomics,X23546.Phospholipids in Small LDL,37021,-0.0028827820848011,0.00458667142157815,-0.0118726580710943,0.00610709390149207,0.529678915874239
CASQ2,Calsequestrin-2,NMR metabolomics,X23547.Cholesterol in Small LDL,37021,-0.00236467022249898,0.00456866465274726,-0.0113192529418836,0.00658991249688565,0.604756865261835
CASQ2,Calsequestrin-2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,37021,-0.00166631901993656,0.00457159547522224,-0.0106266461513721,0.00729400811149902,0.715495025965955
CASQ2,Calsequestrin-2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,37021,-0.00351696988562496,0.00455489411394702,-0.0124445623489611,0.0054106225777112,0.44005136571283
CASQ2,Calsequestrin-2,NMR metabolomics,X23550.Triglycerides in Small LDL,37021,0.00201847116870195,0.00457474344993676,-0.0069480259931741,0.010984968330578,0.659060530418499
CASQ2,Calsequestrin-2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,37021,-0.00233232660779262,0.00535375755702284,-0.0128256914195574,0.00816103820397214,0.66310296559364
CASQ2,Calsequestrin-2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,37021,-0.00130743458509647,0.00536195376394916,-0.0118168639624368,0.00920199479224388,0.807362038865128
CASQ2,Calsequestrin-2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,37021,-0.000502887753631896,0.00529592559219011,-0.0108829019143245,0.00987712640706073,0.92435004515395
CASQ2,Calsequestrin-2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,37021,-0.00235627418224598,0.00544856075875643,-0.0130354532694086,0.00832290490491662,0.665415591290924
CASQ2,Calsequestrin-2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,37021,-0.00382923247434213,0.00551410345041053,-0.0146368752371468,0.00697841028846251,0.487416473718268
CASQ2,Calsequestrin-2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,37021,0.00235338924854473,0.00511973628734445,-0.00768129387465039,0.0123880723717399,0.645760689118054
CASQ2,Calsequestrin-2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,37021,0.0011869770999855,0.00435189360548733,-0.00734273436676967,0.00971668856674067,0.785050008300547
CASQ2,Calsequestrin-2,NMR metabolomics,X23558.Concentration of Large HDL Particles,37021,-0.00660080633902427,0.00547051318494161,-0.0173230121815098,0.00412139950346128,0.227601918772757
CASQ2,Calsequestrin-2,NMR metabolomics,X23559.Total Lipids in Large HDL,37021,-0.00604381177082591,0.00538671896855153,-0.0166017809491869,0.00451415740753509,0.261889769276181
CASQ2,Calsequestrin-2,NMR metabolomics,X23560.Phospholipids in Large HDL,37021,-0.00564537384689177,0.00526822672712814,-0.0159710982320629,0.00468035053827939,0.28392432279167
CASQ2,Calsequestrin-2,NMR metabolomics,X23561.Cholesterol in Large HDL,37021,-0.00681054711972253,0.00551843162419666,-0.017626673103148,0.00400557886370292,0.217170757551538
CASQ2,Calsequestrin-2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,37021,-0.00711398898299211,0.00552892626512466,-0.0179506844626364,0.00372270649665222,0.198226577626348
CASQ2,Calsequestrin-2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,37021,-0.00546783975935258,0.00544253625415381,-0.016135210817494,0.00519953129878889,0.315084262023125
CASQ2,Calsequestrin-2,NMR metabolomics,X23564.Triglycerides in Large HDL,37021,0.000875213043997771,0.00438152635630613,-0.00771257861436224,0.00946300470235778,0.841678630340538
CASQ2,Calsequestrin-2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,37021,-0.00724752285698968,0.00480887168316845,-0.0166729113559998,0.00217786564202048,0.131805172796394
CASQ2,Calsequestrin-2,NMR metabolomics,X23566.Total Lipids in Medium HDL,37021,-0.00644400223333415,0.00473024767154266,-0.0157152876695578,0.00282728320288946,0.17312748556597
CASQ2,Calsequestrin-2,NMR metabolomics,X23567.Phospholipids in Medium HDL,37021,-0.0053317110423108,0.00465053929315381,-0.0144467680568923,0.00378334597227066,0.251620931152188
CASQ2,Calsequestrin-2,NMR metabolomics,X23568.Cholesterol in Medium HDL,37021,-0.00830248629173966,0.00488355583879408,-0.0178742557357761,0.00126928315229674,0.0891375547139363
CASQ2,Calsequestrin-2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,37021,-0.00851779738774614,0.00487339905427965,-0.0180696595341343,0.00103406475864197,0.080519477735935
CASQ2,Calsequestrin-2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,37021,-0.00729121604707354,0.00489897514928513,-0.0168932073396724,0.00231077524552532,0.136691915977302
CASQ2,Calsequestrin-2,NMR metabolomics,X23571.Triglycerides in Medium HDL,37021,0.00341362791690337,0.00443647160518854,-0.00528185642926616,0.0121091122630729,0.441642052670649
CASQ2,Calsequestrin-2,NMR metabolomics,X23572.Concentration of Small HDL Particles,37021,-0.00698383836379546,0.00440508889260123,-0.0156178125932939,0.00165013586570295,0.11289896855351
CASQ2,Calsequestrin-2,NMR metabolomics,X23573.Total Lipids in Small HDL,37021,-0.00515221393673747,0.00442344873504405,-0.0138221734574238,0.00351774558394887,0.244141129650526
CASQ2,Calsequestrin-2,NMR metabolomics,X23574.Phospholipids in Small HDL,37021,-0.00417375320316609,0.00442772163630774,-0.0128520876103293,0.00450458120399707,0.345881718940619
CASQ2,Calsequestrin-2,NMR metabolomics,X23575.Cholesterol in Small HDL,37021,-0.0075383433253595,0.00439932895825069,-0.0161610280835308,0.00108434143281185,0.0866402502837955
CASQ2,Calsequestrin-2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,37021,-0.00749104716023322,0.00438198069895602,-0.016079729330187,0.00109763500972058,0.087379784425325
CASQ2,Calsequestrin-2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,37021,-0.00675523689165421,0.00447367858605174,-0.0155236469203156,0.00201317313700721,0.131068444552776
CASQ2,Calsequestrin-2,NMR metabolomics,X23578.Triglycerides in Small HDL,37021,0.00333651677896493,0.00477237227680688,-0.00601733288357655,0.0126903664415064,0.484482079521402
CASQ2,Calsequestrin-2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36391,-0.00136339102348288,0.00449033559065068,-0.0101644487811582,0.00743766673419246,0.761416458398389
CASQ2,Calsequestrin-2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36391,-0.00269447340038542,0.00447573521246334,-0.0114669144168136,0.00607796761604273,0.547173012288866
CASQ2,Calsequestrin-2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36391,-0.00201102272060962,0.00443838124657793,-0.0107102499639024,0.00668820452268311,0.650485849426456
CASQ2,Calsequestrin-2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36391,-0.00390369437786136,0.00453747587440249,-0.0127971470916902,0.00498975833596752,0.389627535378975
CASQ2,Calsequestrin-2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,36391,0.00173862397060784,0.00438761840834824,-0.00686110810975471,0.0103383560509704,0.691922282710565
CASQ2,Calsequestrin-2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,36855,0.00594236010050366,0.00434618251775168,-0.00257615763428963,0.014460877835297,0.171567574659174
CASQ2,Calsequestrin-2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,36855,-0.00273217526494069,0.00487963563732748,-0.0122962611141026,0.00683191058422117,0.575547895872522
CASQ2,Calsequestrin-2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,36855,-0.00388999068122652,0.00486211428784825,-0.0134197346854091,0.00563975332295606,0.423689763419082
CASQ2,Calsequestrin-2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,36855,0.00218661141751263,0.00465266241811326,-0.00693260692198935,0.0113058297570146,0.638384389682499
CASQ2,Calsequestrin-2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,36855,-0.00086396087633301,0.0047294947156001,-0.0101337705189092,0.00840584876624319,0.855055811198635
CASQ2,Calsequestrin-2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,37017,0.00477746940041,0.00471731566445106,-0.00446846930191407,0.0140234081027341,0.311197406038937
CASQ2,Calsequestrin-2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,37017,0.00161824083145655,0.00453538201575843,-0.00727110791942997,0.0105075895823431,0.7212445298399
CASQ2,Calsequestrin-2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,37017,0.00152100413175975,0.00473678514879814,-0.00776309475988461,0.0108051030234041,0.748136123746273
CASQ2,Calsequestrin-2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,37017,0.00205963257801109,0.00441948112370341,-0.00660255042444759,0.0107218155804698,0.641198212871486
CASQ2,Calsequestrin-2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,37017,-0.00344037430360839,0.00435120014009653,-0.0119687265781976,0.00508797797098081,0.429149377526508
CASQ2,Calsequestrin-2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,37021,0.000365964472393948,0.00478107135277517,-0.00900493537904539,0.00973686432383329,0.938987115976819
CASQ2,Calsequestrin-2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,37021,-0.00319395399095054,0.00497914062750599,-0.0129530696208623,0.0065651616389612,0.521230538857277
CASQ2,Calsequestrin-2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,37021,-0.00362290696505864,0.00499320477657629,-0.0134095883271482,0.00616377439703089,0.468116869377438
CASQ2,Calsequestrin-2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,37021,-0.00172098581951621,0.00488652827672867,-0.0112985812419044,0.00785660960287198,0.724701503203523
CASQ2,Calsequestrin-2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,37021,0.002487438932377,0.00494924463700857,-0.0072130805561598,0.0121879584209138,0.615261244924617
CASQ2,Calsequestrin-2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,37021,-0.00207155888985086,0.00475189778992813,-0.01138527855811,0.00724216077840829,0.662884883002165
CASQ2,Calsequestrin-2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,37021,0.000441657181532964,0.00458305159685716,-0.00854112394830707,0.009424438311373,0.923230177983444
CASQ2,Calsequestrin-2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,37021,0.00246720308002751,0.00445166934219874,-0.00625806883068203,0.011192474990737,0.579437878616813
CASQ2,Calsequestrin-2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,37021,-0.00252940497757016,0.00478567114755207,-0.0119093204267722,0.00685051047163191,0.597135483463785
CASQ2,Calsequestrin-2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,37021,0.000268009554966791,0.00463455939460934,-0.00881572685846751,0.00935174596840109,0.953886125183091
CASQ2,Calsequestrin-2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,37021,0.00646702700799986,0.00463455306187092,-0.00261669699326714,0.0155507510092669,0.162920637161846
CASQ2,Calsequestrin-2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,37021,-0.000156692890943957,0.00487188246446583,-0.00970558252129698,0.00939219673940907,0.974342790103296
CASQ2,Calsequestrin-2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,37021,-0.000650842185384821,0.00492752593826542,-0.010308793024385,0.0090071086536154,0.894920697040877
CASQ2,Calsequestrin-2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,37021,0.00251716158717335,0.00443492481933298,-0.0061752910587193,0.011209614233066,0.570331869372865
CASQ2,Calsequestrin-2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,37021,-0.00169374820624682,0.00482205762096274,-0.0111449811433338,0.00775748473084015,0.725406352178737
CASQ2,Calsequestrin-2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,37021,-0.000421843980106383,0.00448671470687295,-0.00921580480557737,0.00837211684536461,0.925094158284688
CASQ2,Calsequestrin-2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,37021,-0.00126033478032555,0.00468562034271406,-0.0104441506520451,0.00792348109139401,0.787949844683233
CASQ2,Calsequestrin-2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,37021,-0.000908859121334699,0.00464603989439645,-0.0100150973143517,0.00819737907168234,0.844910490624804
CASQ2,Calsequestrin-2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,37021,-0.0020105426307799,0.00457166991771069,-0.0109710156694928,0.00694993040793305,0.660101515446617
CASQ2,Calsequestrin-2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,37021,0.00170475532670765,0.00472489024636789,-0.00755602955617342,0.0109655402095887,0.718252391900248
CASQ2,Calsequestrin-2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,37021,0.00753893955235568,0.00447519198504757,-0.00123243673833756,0.0163103158430489,0.0920881386316084
CASQ2,Calsequestrin-2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,37021,-0.00812756093669087,0.00469814007555833,-0.0173359154847852,0.00108079361140346,0.0836621389368319
CASQ2,Calsequestrin-2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,37021,-0.00918770650115323,0.00442081638915048,-0.0178525066238882,-0.00052290637841829,0.0377026540663028
CASQ2,Calsequestrin-2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,37021,-0.000435131423725636,0.00494998979292587,-0.0101371114178603,0.00926684857040908,0.929953107171642
CASQ2,Calsequestrin-2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,37021,0.00355389021386508,0.00458263728018828,-0.00542807885530395,0.0125358592830341,0.438051110123108
CASQ2,Calsequestrin-2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,37021,-0.00267623078740055,0.00442929528200351,-0.0113576495401274,0.00600518796532632,0.545713504929053
CASQ2,Calsequestrin-2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,37021,-0.000330640350529366,0.00460191764529747,-0.0093503989353124,0.00868911823425367,0.942723658399627
CASQ2,Calsequestrin-2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,37021,0.00344062208300864,0.00458158647060058,-0.00553928739936849,0.0124205315653858,0.45268570169753
CASQ2,Calsequestrin-2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,37021,-0.00691100066665261,0.00480438571369106,-0.0163275966654871,0.00250559533218187,0.150322400749898
CASQ2,Calsequestrin-2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,37021,0.00218131075302881,0.0044764972222005,-0.00659262380248417,0.0109552453085418,0.626067530360763
CASQ2,Calsequestrin-2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,37021,-0.00200947597411784,0.00452981739320421,-0.0108879180647981,0.0068689661165624,0.657331279523867
CASQ2,Calsequestrin-2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,37021,-0.00099508116360024,0.00445449531587083,-0.00972589198270706,0.00773572965550658,0.823236946445218
CASQ2,Calsequestrin-2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,37021,0.00288359806289873,0.00453754950768408,-0.00600999897216207,0.0117771950979595,0.525115520700772
CASQ2,Calsequestrin-2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,37021,-0.00654607084339661,0.00457569081464629,-0.0155144248401033,0.00242228315331013,0.15256314112025
CASQ2,Calsequestrin-2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,37021,0.00417253743425298,0.00459599150556143,-0.00483560591664742,0.0131806807851534,0.363966449396574
CASQ2,Calsequestrin-2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,37018,0.00268838553684534,0.00501318577155612,-0.00713745857540467,0.0125142296490953,0.591785933256498
CASQ2,Calsequestrin-2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,37018,-0.00399426972908356,0.00460498202048549,-0.0130200344892351,0.005031495031068,0.385749603659837
CASQ2,Calsequestrin-2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,37018,-0.00827631224601865,0.00439748105245833,-0.016895375108837,0.000342750616799687,0.0598502582659981
CASQ2,Calsequestrin-2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,37018,0.00660815708705792,0.00529066032362202,-0.00376153714724125,0.0169778513213571,0.211678835900915
CASQ2,Calsequestrin-2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,37018,0.0032256010016106,0.0049242784250772,-0.00642598471154072,0.0128771867147619,0.512453234242483
CASQ2,Calsequestrin-2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,37021,0.00382796863460084,0.00495656664437566,-0.00588690198837545,0.0135428392575771,0.439949174003545
CASQ2,Calsequestrin-2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,37021,-0.00633404314871245,0.00505455290045385,-0.016240966833602,0.00357288053617711,0.210178411082837
CASQ2,Calsequestrin-2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,37021,-0.00725638814767519,0.00488221074727441,-0.016825521212333,0.00231274491698265,0.13722599799934
CASQ2,Calsequestrin-2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,37021,0.00138859381303522,0.00496401872514987,-0.00834088288825853,0.011118070514329,0.779687687407096
CASQ2,Calsequestrin-2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,37021,0.00591948027624176,0.00478174216010746,-0.00345273435756888,0.0152916949100524,0.215762688381816
CASQ2,Calsequestrin-2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,37021,0.0111440843955434,0.00499431985358197,0.00135521748252272,0.020932951308564,0.0256746125165727
CASQ2,Calsequestrin-2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,37021,-0.00975798669131099,0.00489072460594377,-0.0193438069189608,-0.000172166463661205,0.046041363305846
CASQ2,Calsequestrin-2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,37021,-0.00906590727133355,0.00467321476233671,-0.0182254082055135,9.35936628464092e-05,0.0524043892089251
CASQ2,Calsequestrin-2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,37021,-0.00758542207819498,0.005287009558228,-0.0179479608123219,0.00277711665593191,0.151388306207001
CASQ2,Calsequestrin-2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,37021,0.00802110815269911,0.00475214541259543,-0.00129309685598794,0.0173353131613862,0.0914556591610162
CASQ2,Calsequestrin-2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,37021,0.00464052430762224,0.00441232377294976,-0.00400763028735929,0.0132886789026038,0.292947846443202
CASQ2,Calsequestrin-2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,37021,-0.00723885039316473,0.00441815041463621,-0.0158984252058517,0.00142072441952225,0.10135497555569
CASQ2,Calsequestrin-2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,37021,-0.00588067624746214,0.00433466046274785,-0.0143766107544479,0.00261525825952364,0.174911379693154
CASQ2,Calsequestrin-2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,37021,-0.00523597592794087,0.00484155205535306,-0.0147254179564329,0.00425346610055113,0.279509509161179
CASQ2,Calsequestrin-2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,37021,0.00705622170375522,0.00486250170820654,-0.00247428164432961,0.01658672505184,0.146761795744111
CASQ2,Calsequestrin-2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,47284,0.011681069397211,0.00373950295665494,0.00435164360216727,0.0190104951922547,0.0017881277970398
CASQ2,Calsequestrin-2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,47284,0.0122756852412975,0.00366287840091596,0.0050964435755022,0.0194549269070928,0.000805379613128625
CASQ2,Calsequestrin-2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,45557,0.00458707516307127,0.00350681764464815,-0.0022862874204391,0.0114604377465816,0.190871916153943
CASQ2,Calsequestrin-2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,45557,0.00992708517010664,0.00379986753721978,0.00247934479715587,0.0173748255430574,0.00899494013530475
CASQ2,Calsequestrin-2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,45557,0.00830866966639819,0.00376789936470632,0.000923586911573813,0.0156937524212226,0.0274561361540738
CASQ2,Calsequestrin-2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,45557,0.00116028730835099,0.00347689603436107,-0.00565442891899671,0.00797500353569869,0.738598950964612
CASQ2,Calsequestrin-2,Working and living environment,X24009.Traffic intensity on the nearest road,47284,0.200218699574438,0.0457806972843304,0.11048853289715,0.289948866251726,1.2283663106282e-05
CASQ2,Calsequestrin-2,Working and living environment,X24010.Inverse distance to the nearest road,47284,0.00410562826246591,0.00327676892989389,-0.0023168388401261,0.0105280953650579,0.210236340911486
CASQ2,Calsequestrin-2,Working and living environment,X24011.Traffic intensity on the nearest major road,47284,-0.00270672084764762,0.00329879662711567,-0.00917236223679433,0.00375892054149909,0.411929422831964
CASQ2,Calsequestrin-2,Working and living environment,X24012.Inverse distance to the nearest major road,47284,0.00868117291575948,0.00335406751573067,0.00210720058492736,0.0152551452465916,0.00965238723012829
CASQ2,Calsequestrin-2,Working and living environment,X24013.Total traffic load on major roads,47284,0.079337560350506,0.035507027006491,0.00974378741778367,0.148931333283228,0.0254649404607329
CASQ2,Calsequestrin-2,Working and living environment,X24015.Sum of road length of major roads within 100m,47284,0.0668928511079983,0.0345852242912691,-0.000894188502889096,0.134679890718886,0.0531072881163739
CASQ2,Calsequestrin-2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,47284,0.00570072438784975,0.00376094701298811,-0.00167073175760695,0.0130721805333064,0.129591435527726
CASQ2,Calsequestrin-2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,47284,0.00670059745848423,0.00375855391794969,-0.000666168220697155,0.0140673631376656,0.0746384184687696
CASQ2,Calsequestrin-2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,47284,0.00520768675795776,0.00372284735402911,-0.0020890940559393,0.0125044675718548,0.161872680547041
CASQ2,Calsequestrin-2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,47242,0.00177787056585325,0.00359947935398217,-0.00527710896795179,0.0088328500996583,0.621364233849668
CASQ2,Calsequestrin-2,Working and living environment,X24020.Average daytime sound level of noise pollution,47284,0.00789907858098349,0.00328231219808077,0.00146574667274518,0.0143324104892218,0.0161112856767779
CASQ2,Calsequestrin-2,Working and living environment,X24021.Average evening sound level of noise pollution,47284,0.00792876129777432,0.00328210588353279,0.00149583376605005,0.0143616888294986,0.0157102554003701
CASQ2,Calsequestrin-2,Working and living environment,X24022.Average night-time sound level of noise pollution,47284,0.00789614273671937,0.00328242711936893,0.00146258558275626,0.0143296998906825,0.0161544942743655
CASQ2,Calsequestrin-2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,47284,0.00792270101085421,0.00328234046159934,0.00148931370611951,0.0143560883155889,0.0157975498788258
CASQ2,Calsequestrin-2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,47284,0.00792876167801497,0.00328248719368239,0.00149508677839749,0.0143624365776325,0.0157223583792763
CASQ2,Calsequestrin-2,Health and medical history,X2405.Number of children fathered,34312,0.00301621818204547,0.0409877325277085,-0.0773197375722631,0.083352173936354,0.941339377186519
CASQ2,Calsequestrin-2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",44472,-0.00950738352736836,0.00389693842489742,-0.0171453828401673,-0.00186938421456942,0.0147075955765384
CASQ2,Calsequestrin-2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",44472,0.00791361360001106,0.00355142296424923,0.000952824590082567,0.0148744026099396,0.0258716773232793
CASQ2,Calsequestrin-2,Working and living environment,"X24502.Water percentage, buffer 1000m",44472,0.00165208358253016,0.00345969798190767,-0.00512892446200886,0.00843309162706918,0.632995175897164
CASQ2,Calsequestrin-2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",44472,-0.00917710267030902,0.0036831678161006,-0.0163961115898662,-0.00195809375075184,0.012723531806759
CASQ2,Calsequestrin-2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",44472,0.00551182434877526,0.00360441175048353,-0.00155282268217246,0.012576471379723,0.126233110661453
CASQ2,Calsequestrin-2,Working and living environment,"X24505.Water percentage, buffer 300m",44472,0.00336540128140146,0.00348448357145597,-0.00346418651865225,0.0101949890814552,0.334143097161621
CASQ2,Calsequestrin-2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",47369,-0.00877335289817162,0.00367292272321141,-0.015972281435666,-0.00157442436067725,0.0169179171991826
CASQ2,Calsequestrin-2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",47369,-0.00762453641986413,0.00346736306304166,-0.0144205680234258,-0.000828504816302485,0.0278916247926442
CASQ2,Calsequestrin-2,Working and living environment,X24508.Distance (Euclidean) to coast,47369,0.0033221308873983,0.00331389429370124,-0.00317310192825612,0.00981736370305273,0.316119497533314
CASQ2,Calsequestrin-2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,27953,0.0836472313144216,0.05695064765933,-0.0279760380978652,0.195270500726708,0.141972848831672
CASQ2,Calsequestrin-2,Health and medical history,X2704.Years since last cervical smear test,33780,0.0338882659120183,0.0365472166689182,-0.0377442787590615,0.105520810583098,0.353821305798634
CASQ2,Calsequestrin-2,Health and medical history,X2714.Age when periods started (menarche),36598,0.0231593876864202,0.0320765300113011,-0.03971061113573,0.0860293865085704,0.47030518134477
CASQ2,Calsequestrin-2,Health and medical history,X2734.Number of live births,36999,0.0384524785691264,0.0309478646316287,-0.0222053361088659,0.0991102932471187,0.214077224876138
CASQ2,Calsequestrin-2,Health and medical history,X2744.Birth weight of first child,33761,0.0505922677349658,0.0347396352970387,-0.01749741744723,0.118681952917162,0.145333988656081
CASQ2,Calsequestrin-2,Health and medical history,X2754.Age at first live birth,32042,0.00249587669124651,0.0057280499252754,-0.00873110116229327,0.0137228545447863,0.66304495388991
CASQ2,Calsequestrin-2,Health and medical history,X2764.Age at last live birth,32019,-0.00274405056254565,0.00574185025583578,-0.0139980770639838,0.00850997593889248,0.632731663407115
CASQ2,Calsequestrin-2,Health and medical history,X2794.Age started oral contraceptive pill,35052,0.00462059966405653,0.00567999998986924,-0.00651220031608718,0.0157533996442002,0.415956855240159
CASQ2,Calsequestrin-2,Health and medical history,X2804.Age when last used oral contraceptive pill,34028,0.000496985353840864,0.00501403145332196,-0.00933051629467018,0.0103244870023519,0.921045808345446
CASQ2,Calsequestrin-2,Lifestyle factors,X2867.Age started smoking in former smokers,28500,-0.000338345181314615,0.00705615555665122,-0.014168410072351,0.0134917197097218,0.961757869729938
CASQ2,Calsequestrin-2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",34127,0.0535094875727253,0.042263794004877,-0.0293275486768337,0.136346523822284,0.205511960433877
CASQ2,Calsequestrin-2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,34124,0.0175282709766049,0.0476471682463342,-0.0758601787862102,0.11091672073942,0.712972950154732
CASQ2,Calsequestrin-2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,34141,0.0586540809333296,0.0479836927739234,-0.0353939569035604,0.152702118770219,0.221593762784909
CASQ2,Calsequestrin-2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",34114,-0.00542719386216543,0.0483144444113069,-0.100123504908327,0.089269117183996,0.910563424583047
CASQ2,Calsequestrin-2,Mental health,X28739.Difficulty with standing for long periods,34158,-0.0363417978898862,0.0460077862295344,-0.126517058899774,0.0538334631200013,0.42960122183932
CASQ2,Calsequestrin-2,Mental health,X28740.Difficulty with taking care of household responsibilities,34175,-0.0480472454703007,0.052133428210756,-0.150228764763383,0.054134273822781,0.35674802940767
CASQ2,Calsequestrin-2,Mental health,X28741.Difficulty learning a new task,34097,0.0147614531864442,0.0564265312472891,-0.0958345480582424,0.125357454431131,0.793631383457637
CASQ2,Calsequestrin-2,Mental health,X28742.Difficulty with joining in community activities,33730,0.0796050028999312,0.0526598349807989,-0.0236082736624345,0.182818279462297,0.130646426491148
CASQ2,Calsequestrin-2,Mental health,X28743.Difficulty with being emotionally affected by health problems,34100,0.0341945376032483,0.0459037288657143,-0.0557767709735518,0.124165846180048,0.456338081433478
CASQ2,Calsequestrin-2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,34172,0.0287702803770847,0.0635668386153332,-0.0958207233089684,0.153361284063138,0.650847124737305
CASQ2,Calsequestrin-2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,28373,0.0650470780598683,0.0610402192991867,-0.0545917517665376,0.184685907886274,0.286642105362874
CASQ2,Calsequestrin-2,Lifestyle factors,X2897.Age stopped smoking,28502,-0.00255594069025136,0.00852833558196791,-0.0192714784309085,0.0141595970504057,0.764419549678586
CASQ2,Calsequestrin-2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,33033,0.00952240554296911,0.0106803816454856,-0.0114111424821827,0.0304559535681209,0.372641937718213
CASQ2,Calsequestrin-2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,33033,-0.0184350961030505,0.0114518563019121,-0.0408807344547983,0.00401054224869729,0.107477883076208
CASQ2,Calsequestrin-2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,33033,0.0628173082213235,0.0387266100631388,-0.0130868475024285,0.138721463945076,0.104822529074691
CASQ2,Calsequestrin-2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,33033,0.0503067809594026,0.0383417952398436,-0.0248431377106909,0.125456699629496,0.189532326230507
CASQ2,Calsequestrin-2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,33033,0.0158002278282465,0.0405768467437324,-0.0637303917894689,0.095330847445962,0.696996534894599
CASQ2,Calsequestrin-2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,33033,-0.029590649930966,0.0344498033979318,-0.0971122645909124,0.0379309647289804,0.390390686144809
CASQ2,Calsequestrin-2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,33033,-0.00388485855830221,0.0159469661193621,-0.0351409121522518,0.0273711950356474,0.807537449217385
CASQ2,Calsequestrin-2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,33033,0.0392328146967124,0.0289165778749192,-0.0174436779381292,0.0959093073315541,0.174891324031478
CASQ2,Calsequestrin-2,Mental health,X29002.Recent lack of interest or pleasure in doing things,32983,0.0574898632258484,0.0494583395225875,-0.0394484822384232,0.15442820869012,0.245107628131931
CASQ2,Calsequestrin-2,Mental health,X29003.Recent feelings of depression,32981,0.0544477017497709,0.0477410796294925,-0.0391248143240344,0.148020217823576,0.254116722514888
CASQ2,Calsequestrin-2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",32988,0.0421638315689318,0.0397230130686519,-0.035693274045626,0.12002093718349,0.288515370137917
CASQ2,Calsequestrin-2,Mental health,X29005.Recent feelings of tiredness or low energy,32994,0.0320980263983023,0.0403357260066465,-0.0469599965747249,0.11115604937133,0.426185468802971
CASQ2,Calsequestrin-2,Mental health,X29006.Recent poor appetite or overeating,32996,0.0427518903091272,0.0527010408726816,-0.0605421498013287,0.146045930419583,0.417263182127878
CASQ2,Calsequestrin-2,Mental health,X29007.Recent feelings of inadequacy,32963,0.0315106926116283,0.0514694951567042,-0.0693695178955118,0.132390903118768,0.540407013625097
CASQ2,Calsequestrin-2,Mental health,X29008.Recent trouble concentrating on things,32993,0.0455993127693358,0.0516990206860792,-0.0557307677753794,0.146929393314051,0.377791902411392
CASQ2,Calsequestrin-2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,32984,0.093005530405051,0.0888591595003398,-0.0811584222156151,0.267169483025717,0.295283099277187
CASQ2,Calsequestrin-2,Mental health,X29010.Recent thoughts of suicide or self-harm,32929,-0.00307467697540007,0.103167693914801,-0.20528335704841,0.19913400309761,0.976225052524874
CASQ2,Calsequestrin-2,Mental health,X29038#0.Substances taken for depression_None of options listed,31313,0.0154524651841595,0.0204117677790412,-0.0245545996627613,0.0554595300310803,0.449051575925753
CASQ2,Calsequestrin-2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),31313,0.0219464891708178,0.0355522526285988,-0.0477359259812359,0.0916289043228715,0.537054174028531
CASQ2,Calsequestrin-2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),31313,-0.00526478135563646,0.0201811471886755,-0.0448198298454404,0.0342902671341675,0.794195172780014
CASQ2,Calsequestrin-2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),31313,0.0351065463861682,0.0583570109839002,-0.0792731951422763,0.149486287914613,0.547470494277946
CASQ2,Calsequestrin-2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),31313,-0.0020100065264032,0.0345590493002373,-0.0697457431548683,0.0657257301020619,0.95362153778899
CASQ2,Calsequestrin-2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),31313,-0.0165387467082135,0.0373465437496071,-0.0897379724574435,0.0566604790410164,0.657890383639136
CASQ2,Calsequestrin-2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),31313,-0.0140615031755233,0.0437884732049521,-0.0998869106572295,0.0717639043061829,0.748125885988819
CASQ2,Calsequestrin-2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),31313,-0.0941552518982129,0.0500305318919567,-0.192215094406448,0.00390459061002216,0.0598809436459692
CASQ2,Calsequestrin-2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),31313,-0.0478769901462502,0.0402183761125547,-0.126705007326857,0.0309510270343571,0.23391701608661
CASQ2,Calsequestrin-2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,31313,0.0346455744338145,0.0206272381425672,-0.00578381232561727,0.0750749611932463,0.093076464936657
CASQ2,Calsequestrin-2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,31313,0.0233126724575088,0.0299986589536249,-0.035484699091596,0.0821100440066136,0.437110385798559
CASQ2,Calsequestrin-2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,31313,-0.0445375511743415,0.0475648693127462,-0.137764695027324,0.0486895926786412,0.349121340743949
CASQ2,Calsequestrin-2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,31313,-0.106050457575324,0.0591143802721991,-0.221914642908835,0.00981372775818598,0.0728556872839427
CASQ2,Calsequestrin-2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,31313,0.00910277068303818,0.0378496328952417,-0.0650825097916355,0.0832880511577119,0.809950630233884
CASQ2,Calsequestrin-2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,31313,0.037112452978643,0.0608469967390153,-0.0821476606298269,0.156372566587113,0.541926291771629
CASQ2,Calsequestrin-2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,31313,-0.0497000588973647,0.0575857801629287,-0.162568188016705,0.0631680702219756,0.388131529632777
CASQ2,Calsequestrin-2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,31313,-0.00943148910197941,0.0317067258102778,-0.0715766716901239,0.0527136934861651,0.766123477334356
CASQ2,Calsequestrin-2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,31313,0.0235007029110358,0.031121729194694,-0.0374978863105645,0.0844992921326361,0.450199635224432
CASQ2,Calsequestrin-2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,31313,-0.0396284803648288,0.0443694285321388,-0.126592560287821,0.0473355995581633,0.371806589323138
CASQ2,Calsequestrin-2,Mental health,X29058.Recent feelings or nervousness or anxiety,32846,-0.0324712052650216,0.0473053423302245,-0.125189676232262,0.0602472657022185,0.492467714375521
CASQ2,Calsequestrin-2,Mental health,X29059.Recent inability to stop or control worrying,32850,0.0187572624308376,0.0486354953322663,-0.0765683084204044,0.11408283328208,0.699750044405791
CASQ2,Calsequestrin-2,Mental health,X29060.Recent worrying too much about different things,32845,0.0420462751045082,0.044280031656923,-0.0447425869430609,0.128835137152077,0.34236453608087
CASQ2,Calsequestrin-2,Mental health,X29061.Recent trouble relaxing,32850,0.00166393435676725,0.0468069114321247,-0.0900776120501971,0.0934054807637316,0.971642841423296
CASQ2,Calsequestrin-2,Mental health,X29062.Recent restlessness,32852,0.0449950764929306,0.0644892698648247,-0.0814038924421258,0.171394045427987,0.485374017542967
CASQ2,Calsequestrin-2,Mental health,X29063.Recent easy annoyance or irritability,32837,0.0132963218516386,0.0473279015528424,-0.0794663651919326,0.10605900889521,0.77876255266273
CASQ2,Calsequestrin-2,Mental health,X29064.Recent feelings of foreboding,32829,-0.00492548601592939,0.0545724724138453,-0.111887531947066,0.102036559915207,0.9280859028638
CASQ2,Calsequestrin-2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,31313,-0.0241649595512374,0.0208212052247453,-0.0649745217917381,0.0166446026892633,0.245844343024569
CASQ2,Calsequestrin-2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,31313,-0.0502345719981278,0.0337782195845989,-0.116439882383942,0.015970738387686,0.1370073958204
CASQ2,Calsequestrin-2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',31313,-0.000545752410850717,0.0453019798605621,-0.0893376329375525,0.0882461281158511,0.990388449153791
CASQ2,Calsequestrin-2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,31313,-0.0376421114835423,0.049378190785153,-0.134423365422442,0.0591391424553576,0.445891604357902
CASQ2,Calsequestrin-2,Mental health,X29065#2.Symptoms of panic attack_Sweating,31313,-0.0212030264723712,0.0314763282097588,-0.0828966297634985,0.0404905768187561,0.500574989770917
CASQ2,Calsequestrin-2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,31313,-0.0322013139182678,0.0339353760068302,-0.098714650891655,0.0343120230551193,0.342701707341903
CASQ2,Calsequestrin-2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,31313,-0.0286345871809655,0.0338644544281437,-0.0950089178601272,0.0377397434981962,0.397822770818532
CASQ2,Calsequestrin-2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,31313,-0.0357002697102365,0.0311167808639033,-0.0966891602034869,0.0252886207830139,0.251294653966668
CASQ2,Calsequestrin-2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,31313,0.0199690335633515,0.0409648864381855,-0.060322143855492,0.100260210982195,0.62594170424517
CASQ2,Calsequestrin-2,Mental health,X29076.Felt loved as a child,32813,0.0130987312180469,0.0420857127933108,-0.0693892658568423,0.095586728292936,0.755625895425488
CASQ2,Calsequestrin-2,Mental health,X29077.Physically abused by family as a child,32818,-0.00371933403977646,0.0544280959149383,-0.110398402033056,0.102959733953503,0.945520633641523
CASQ2,Calsequestrin-2,Mental health,X29078.Felt hated by family member as a child,32805,0.000403004056411707,0.055559168537602,-0.108492966277288,0.109298974390112,0.994212676083713
CASQ2,Calsequestrin-2,Mental health,X29079.Sexually molested as a child,32742,-0.0263463324007247,0.076733651460251,-0.176744289262817,0.124051624461367,0.731344934354649
CASQ2,Calsequestrin-2,Mental health,X29080.Someone to take to doctor when needed as a child,32803,0.0536830997425946,0.0655871722938966,-0.0748677579534427,0.182233957438632,0.413093564873392
CASQ2,Calsequestrin-2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,32804,0.0310241802185754,0.0756597142186712,-0.11726885965002,0.179317220087171,0.68177992185731
CASQ2,Calsequestrin-2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,32757,0.0464139893954458,0.0580969418135274,-0.0674560165590679,0.160283995349959,0.424366307827859
CASQ2,Calsequestrin-2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,32811,0.0416776429880854,0.0644625513112482,-0.0846689575819611,0.168024243558132,0.517946028105131
CASQ2,Calsequestrin-2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,32780,-0.0514323334895954,0.0971053501996571,-0.241758819880923,0.138894152901733,0.596364342156685
CASQ2,Calsequestrin-2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,32779,0.0196211345603998,0.0900605967155896,-0.156897635002156,0.196139904122955,0.82753856750839
CASQ2,Calsequestrin-2,Mental health,X29086.Experienced a violent or sexual assault,32810,0.0317010978654141,0.0714890693594753,-0.108417478079157,0.171819673809986,0.657458381146722
CASQ2,Calsequestrin-2,Mental health,X29087.Experienced a life-threatening injury or illness,32819,0.0112480048999689,0.0509238215239809,-0.0885626852870337,0.111058695086972,0.825191650640028
CASQ2,Calsequestrin-2,Mental health,X29088.Experienced a marital separation or divorce,32819,-0.0420456257275476,0.0463416499121502,-0.132875259555362,0.0487840081002668,0.364274327725233
CASQ2,Calsequestrin-2,Mental health,X29089.Experienced the death of a spouse or partner,32828,-0.0174623835110294,0.0739229115232089,-0.162351290096519,0.12742652307446,0.81326406707796
CASQ2,Calsequestrin-2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,32816,0.0229239050174713,0.056047300733218,-0.086928804419636,0.132776614454579,0.682542122812697
CASQ2,Calsequestrin-2,Lifestyle factors,X29091.Frequency of drinking alcohol,32822,0.00753632387990265,0.0378309770000025,-0.0666123910401022,0.0816850387999075,0.842102688928939
CASQ2,Calsequestrin-2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,31892,0.0126135338402067,0.0430788888381201,-0.0718210882825087,0.0970481559629222,0.769681970270251
CASQ2,Calsequestrin-2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,31905,0.0030654820599647,0.0430191304849379,-0.0812520136905136,0.087382977810443,0.94319373336602
CASQ2,Calsequestrin-2,Mental health,X29104.Ever used cannabis,32812,0.0474412212265503,0.0495141832936062,-0.0496065780289179,0.144489020482019,0.338021089439511
CASQ2,Calsequestrin-2,Mental health,X29108.Ever thought that life not worth living,32776,-0.01264345304043,0.0467403708481853,-0.104254579902873,0.0789676738220133,0.786778871643213
CASQ2,Calsequestrin-2,Mental health,X29109.Ever contemplated self-harm,32786,0.00323298452431622,0.0605855878030035,-0.115514767569571,0.121980736618203,0.957444460453864
CASQ2,Calsequestrin-2,Mental health,X29111.Ever self-harmed,32805,0.0171116195439095,0.0948863233277588,-0.168865574178498,0.203088813266317,0.85689122988566
CASQ2,Calsequestrin-2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,32811,-0.00720640527705807,0.066436000567504,-0.137420966389366,0.12300815583525,0.913624206255688
CASQ2,Calsequestrin-2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,31858,-0.0672913700975933,0.0425632226393873,-0.150715286470792,0.0161325462756059,0.113923408339722
CASQ2,Calsequestrin-2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,31858,-0.00740481899683298,0.034010547494081,-0.0740654920852318,0.0592558540915659,0.827651857906005
CASQ2,Calsequestrin-2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,31858,-0.0445103479394043,0.0349858124045283,-0.11308254025228,0.0240618443734711,0.203324867054037
CASQ2,Calsequestrin-2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,31858,-0.0733594315870102,0.0466826566642213,-0.164857438648884,0.0181385754748635,0.116117861473394
CASQ2,Calsequestrin-2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,32801,-0.0300959127589296,0.0430104086886147,-0.114396313788614,0.0542044882707551,0.484110665908587
CASQ2,Calsequestrin-2,Health and medical history,X29153.Pain or discomfort today,32814,-0.025590930914632,0.0407406519628216,-0.105442608761762,0.0542607469324984,0.529926684932548
CASQ2,Calsequestrin-2,Mental health,X29154.Anxiety or depression today,32814,-0.0343617191186194,0.0514965381030846,-0.135294933800665,0.0665714955634265,0.5046215476625
CASQ2,Calsequestrin-2,Mental health,X29166.Frequency of confiding in someone close,32612,0.0353504146106856,0.0396504810736677,-0.0423645282937031,0.113065357515074,0.372658319589011
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,32786,0.00196292664757446,0.0111548870470675,-0.0199006519646778,0.0238265052598267,0.860321420361877
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,32786,0.00972775939510905,0.0110925606473254,-0.0120136594736487,0.0314691782638668,0.380530623897771
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,32786,-0.00882216331226124,0.0138959426896028,-0.0360582109838827,0.0184138843593602,0.525527309565119
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,32786,-0.0323846011542173,0.0163036471689163,-0.0643397496052932,-0.000429452703141465,0.0470260158417923
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,32786,-0.0100150215048412,0.0252488846684473,-0.0595028354549979,0.0394727924453154,0.691633557003887
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,32786,3.28480861205124e-05,0.0119396897744688,-0.0233689438718384,0.0234346400440794,0.997804950200138
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,32782,0.0118638360352151,0.0130383042604013,-0.0136912403151715,0.0374189123856016,0.362888382819528
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,32782,0.00557317702111368,0.0185002280818428,-0.0306872700192982,0.0418336240615256,0.763231573216499
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,32782,-0.00222808381083257,0.0297173639392593,-0.0604741171317808,0.0560179495101157,0.940235629319213
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,32782,-0.0394387015698843,0.0293422219298667,-0.0969494565524229,0.0180720534126544,0.178952199487954
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,32782,-0.00881803745332249,0.0395852678083019,-0.0864051623575942,0.0687690874509492,0.823726944316309
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,32782,-0.0343621343704378,0.0193276665090014,-0.0722443607280806,0.003520091987205,0.0754587846228805
CASQ2,Calsequestrin-2,Mental health,X29171.Frequency of feeling 'in tune' with people,32631,0.0648588227261085,0.0499584830315128,-0.0330598040156566,0.162777449467874,0.194234053489856
CASQ2,Calsequestrin-2,Mental health,X29172.Freuency of feeling that lacks companionship,32742,-0.0167763094101136,0.0440875354443824,-0.103187878881103,0.069635260060876,0.70356652686761
CASQ2,Calsequestrin-2,Mental health,X29173.Frequency of feeling left out,32699,0.013433377345664,0.0459660263970944,-0.076660034392641,0.103526789083969,0.770105569311562
CASQ2,Calsequestrin-2,Mental health,X29174.Frequency of feeling isolated from others,32728,-0.0427714293301089,0.0477725102584701,-0.13640554943671,0.0508626907764925,0.370643202642126
CASQ2,Calsequestrin-2,Mental health,X29175.Tendency to bounce back quickly after hard times,32799,-0.0110956368500188,0.0396785744274907,-0.0888656427279005,0.0666743690278629,0.779761728689759
CASQ2,Calsequestrin-2,Mental health,X29176.Ability to make it through stressful events,32799,-0.0482425700133517,0.0380783120631437,-0.122876061657113,0.02639092163041,0.20521320659576
CASQ2,Calsequestrin-2,Mental health,X29177.Quick recovery from stressful events,32799,0.0181929898470607,0.0396698882419026,-0.0595599911070685,0.0959459708011898,0.646525726161588
CASQ2,Calsequestrin-2,Mental health,X29178.Hard to snap back when something bad happens,32799,-0.0467437324550677,0.0385591578837807,-0.122319681907278,0.0288322169971425,0.225444843753839
CASQ2,Calsequestrin-2,Mental health,X29179.Comes through difficult times with little trouble,32799,0.00246494568569281,0.0395852839179507,-0.0751222107934906,0.0800521021648762,0.950349813666591
CASQ2,Calsequestrin-2,Mental health,X29180.Tendency to take a long time to get over setbacks,32799,-0.0929395269989149,0.0391273162142555,-0.169629066778856,-0.0162499872189742,0.0175551649904093
CASQ2,Calsequestrin-2,Mental health,X29181.General happiness,32743,0.00018275600616699,0.040638413978202,-0.079468535391109,0.0798340474034429,0.996411926936946
CASQ2,Calsequestrin-2,Mental health,X29182.Belief that own life is meaningful,32659,0.0380982083179511,0.0402555500670466,-0.0408026698134603,0.116999086449362,0.343966097432537
CASQ2,Calsequestrin-2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,28104,-0.00443013167668948,0.0609500392717055,-0.123892208649232,0.115031945295853,0.942060497460599
CASQ2,Calsequestrin-2,Health and medical history,X2946.Father's age,32427,-0.00508878948660185,0.00810542403571895,-0.020975420596611,0.0107978416234073,0.530135188424923
CASQ2,Calsequestrin-2,Health and medical history,X2966.Age high blood pressure diagnosed,28218,0.0324982174299061,0.0130800227572367,0.00686137282572226,0.0581350620340899,0.01300810769513
CASQ2,Calsequestrin-2,Blood and urine assays,X30000.White blood cell (leukocyte) count,46867,0.00570343676122956,0.00341893005829426,-0.000997666153027186,0.0124045396754863,0.0952909368776818
CASQ2,Calsequestrin-2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,46867,-0.00350093423513264,0.00404117344270777,-0.0114216341828399,0.0044197657125746,0.386325789734251
CASQ2,Calsequestrin-2,Blood and urine assays,X30020.Haemoglobin concentration,46867,-0.0030099182189511,0.00431483055304263,-0.0114669861029146,0.00544714966501245,0.48545002691603
CASQ2,Calsequestrin-2,Blood and urine assays,X30030.Haematocrit percentage,46867,-0.00352591319372366,0.00422967438030546,-0.0118160749791224,0.00476424859167505,0.404507532677288
CASQ2,Calsequestrin-2,Blood and urine assays,X30040.Mean corpuscular volume,46867,0.000186906481824449,0.00341324603471425,-0.00650305574621548,0.00687686870986438,0.956330813537991
CASQ2,Calsequestrin-2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,46866,0.00105887046659085,0.00342141803133373,-0.00564710887482326,0.00776484980800495,0.756957000309338
CASQ2,Calsequestrin-2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,46866,0.00128100541446511,0.00334592639188065,-0.00527701031362098,0.00783902114255119,0.70183064596554
CASQ2,Calsequestrin-2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,46867,0.00527964469114494,0.00325916636228174,-0.00110832137892726,0.0116676107612171,0.10525948240307
CASQ2,Calsequestrin-2,Blood and urine assays,X30080.Platelet count,46867,0.00066306673023788,0.00344323011109573,-0.00608566428750975,0.00741179774798551,0.847296552466154
CASQ2,Calsequestrin-2,Blood and urine assays,X30090.Platelet crit,46867,0.000687095074692438,0.0035281014282162,-0.00622798372461132,0.00760217387399619,0.845590980854799
CASQ2,Calsequestrin-2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,46867,-0.000541577748869429,0.00331388594423345,-0.007036794199567,0.00595363870182814,0.870183844950227
CASQ2,Calsequestrin-2,Blood and urine assays,X30110.Platelet distribution width,46867,0.00143888000403375,0.00328872671206172,-0.00500702435160722,0.00788478435967473,0.66173919902285
CASQ2,Calsequestrin-2,Blood and urine assays,X30120.Lymphocyte count,46836,0.00292312646055243,0.00347803676475865,-0.00389382559837453,0.00974007851947939,0.400663184763612
CASQ2,Calsequestrin-2,Blood and urine assays,X30130.Monocyte count,46836,0.00217038562437841,0.00348057570778617,-0.00465154276288248,0.0089923140116393,0.532915635965699
CASQ2,Calsequestrin-2,Blood and urine assays,X30140.Neutrophill count,46836,0.00557819203583629,0.00339522775271251,-0.00107645435948022,0.0122328384311528,0.10040680400518
CASQ2,Calsequestrin-2,Blood and urine assays,X30150.Eosinophill count,46836,0.00618103377360175,0.00331317374514872,-0.000312786766889745,0.0126748543140932,0.0621110630174003
CASQ2,Calsequestrin-2,Blood and urine assays,X30160.Basophill count,46836,0.0126253641344094,0.0270038016438883,-0.0403020870876117,0.0655528153564304,0.640117837363525
CASQ2,Calsequestrin-2,Blood and urine assays,X30170.Nucleated red blood cell count,46836,0.0629752383855074,0.112580816022092,-0.157683161017794,0.283633637788809,0.575909184764243
CASQ2,Calsequestrin-2,Blood and urine assays,X30180.Lymphocyte percentage,46836,-0.0025820907937882,0.00342569571046071,-0.0092964543862912,0.0041322727987148,0.451011870863375
CASQ2,Calsequestrin-2,Blood and urine assays,X30190.Monocyte percentage,46836,-0.00195689894202037,0.00343193004933166,-0.00868348183871043,0.00476968395466968,0.568545175852885
CASQ2,Calsequestrin-2,Blood and urine assays,X30200.Neutrophill percentage,46836,0.00180926829536503,0.00337145816359905,-0.00479878970528911,0.00841732629601917,0.591519662866336
CASQ2,Calsequestrin-2,Blood and urine assays,X30210.Eosinophill percentage,46836,0.00554043464690622,0.00326800949126819,-0.000864863955979439,0.0119457332497919,0.0900217383317486
CASQ2,Calsequestrin-2,Blood and urine assays,X30220.Basophill percentage,46836,-0.00241709011732638,0.0032641563723722,-0.00881483660717589,0.00398065637252314,0.459007512782163
CASQ2,Calsequestrin-2,Blood and urine assays,X30230.Nucleated red blood cell percentage,46836,0.0683407994711698,0.112582630660223,-0.152321156622866,0.289002755565206,0.543838385948484
CASQ2,Calsequestrin-2,Blood and urine assays,X30240.Reticulocyte percentage,46449,-0.00131267648192341,0.00350900577788048,-0.00819032780656914,0.00556497484272233,0.708342457360425
CASQ2,Calsequestrin-2,Blood and urine assays,X30250.Reticulocyte count,46449,-0.00209673739065748,0.00359990256099011,-0.0091525464101981,0.00495907162888313,0.560274261042779
CASQ2,Calsequestrin-2,Blood and urine assays,X30260.Mean reticulocyte volume,46449,0.00070415809936914,0.00338250009218636,-0.00592554208131612,0.0073338582800544,0.835092787006612
CASQ2,Calsequestrin-2,Blood and urine assays,X30270.Mean sphered cell volume,46449,0.001615424676902,0.00340042546132494,-0.00504940922729489,0.00828025858109889,0.634744911430028
CASQ2,Calsequestrin-2,Blood and urine assays,X30280.Immature reticulocyte fraction,46449,0.00551048658058374,0.00353438678648032,-0.00141691152091769,0.0124378846820852,0.118985106290995
CASQ2,Calsequestrin-2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,46449,0.00132390494309937,0.00358750734511932,-0.0057076094533345,0.00835541933953324,0.712107345797015
CASQ2,Calsequestrin-2,Blood and urine assays,X30300.High light scatter reticulocyte count,46449,0.00067309282929517,0.00364989050044064,-0.00648069255156849,0.00782687821015883,0.853689930012516
CASQ2,Calsequestrin-2,Blood and urine assays,X30500.Microalbumin in urine,30757,0.00498194455358263,0.00620857985849855,-0.00718687196907452,0.0171507610762398,0.422332489219012
CASQ2,Calsequestrin-2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,46987,-0.00154311761624698,0.00348300141570944,-0.00836980039103748,0.00528356515854351,0.657739146222685
CASQ2,Calsequestrin-2,Blood and urine assays,X30520.Potassium in urine,46940,0.000432897112009072,0.00322469499000029,-0.0058875050683915,0.00675329929240964,0.893210520437339
CASQ2,Calsequestrin-2,Blood and urine assays,X30530.Sodium in urine,46939,-0.00229449872552086,0.00336628921336895,-0.00889242558372401,0.00430342813268229,0.495491990886616
CASQ2,Calsequestrin-2,Blood and urine assays,X30600.Albumin,44606,-0.00262215451951614,0.00364692846466765,-0.00977013431026473,0.00452582527123244,0.472146829458476
CASQ2,Calsequestrin-2,Blood and urine assays,X30610.Alkaline phosphatase,46518,0.00779687751002711,0.00342969883705538,0.00107466778939856,0.0145190872306557,0.0230149110009689
CASQ2,Calsequestrin-2,Blood and urine assays,X30620.Alanine aminotransferase,46509,0.00323546240886505,0.00362909943966059,-0.00387757249286971,0.0103484973105998,0.372652693291431
CASQ2,Calsequestrin-2,Blood and urine assays,X30630.Apolipoprotein A,44482,-0.0120909163415227,0.00397395037116803,-0.019879859069012,-0.00430197361403333,0.00234883004500349
CASQ2,Calsequestrin-2,Blood and urine assays,X30640.Apolipoprotein B,46369,0.00194304425970833,0.00349143963581714,-0.00490017742649327,0.00878626594590992,0.577863253847789
CASQ2,Calsequestrin-2,Blood and urine assays,X30650.Aspartate aminotransferase,46444,0.00934291883624674,0.00340124527304421,0.00267647810108009,0.0160093595714134,0.00602070857186108
CASQ2,Calsequestrin-2,Blood and urine assays,X30660.Direct bilirubin,42951,-0.00776298860664712,0.00371032397442096,-0.0150352235965122,-0.000490753616782044,0.0364278064831818
CASQ2,Calsequestrin-2,Blood and urine assays,X30670.Urea,46513,0.000478212880807434,0.00358615419397461,-0.0065506493393828,0.00750707510099767,0.893917943097752
CASQ2,Calsequestrin-2,Blood and urine assays,X30680.Calcium,44603,0.000908567570914302,0.00354747124152479,-0.00604447606247428,0.00786161120430288,0.797863061681582
CASQ2,Calsequestrin-2,Blood and urine assays,X30690.Cholesterol,46523,0.000938359048261412,0.00358772619725819,-0.00609358429836464,0.00797030239488746,0.793673081203385
CASQ2,Calsequestrin-2,Blood and urine assays,X30700.Creatinine,46517,2.75593390166575e-05,0.00437558090972455,-0.00854857924404346,0.00860369792207678,0.994974659698703
CASQ2,Calsequestrin-2,Blood and urine assays,X30710.C-reactive protein,46448,0.00455351275157803,0.00371742776582269,-0.00273264566943443,0.0118396711725905,0.220622077141428
CASQ2,Calsequestrin-2,Blood and urine assays,X30720.Cystatin C,46521,0.00651617229130928,0.00402111603732241,-0.00136521514184264,0.0143975597244612,0.10514129671229
CASQ2,Calsequestrin-2,Blood and urine assays,X30730.Gamma glutamyltransferase,46514,-0.00123200240817666,0.00371085641257688,-0.00850528097682735,0.00604127616047403,0.739892721325115
CASQ2,Calsequestrin-2,Blood and urine assays,X30740.Glucose,44572,-0.00220668152443277,0.00361549602985557,-0.00929305374294969,0.00487969069408415,0.54164336057908
CASQ2,Calsequestrin-2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),46357,0.00178057906551383,0.00358293369921455,-0.00524197098494668,0.00880312911597434,0.619221262155225
CASQ2,Calsequestrin-2,Blood and urine assays,X30760.HDL cholesterol,44587,-0.011532299763523,0.00420569339125711,-0.0197754588103869,-0.00328914071665903,0.00611059717803728
CASQ2,Calsequestrin-2,Blood and urine assays,X30770.IGF-1,46415,-0.000764430244845451,0.00352291096888067,-0.00766933574385157,0.00614047525416067,0.828219473637443
CASQ2,Calsequestrin-2,Blood and urine assays,X30780.LDL direct,46473,0.00144288931009096,0.00354865167422458,-0.00551246797138921,0.00839824659157114,0.684304084584358
CASQ2,Calsequestrin-2,Blood and urine assays,X30790.Lipoprotein A,42020,0.000406650020008277,0.00375080901578467,-0.00694493565092967,0.00775823569094622,0.913666419107209
CASQ2,Calsequestrin-2,Blood and urine assays,X30810.Phosphate,44553,0.00274437619443768,0.00354888647954841,-0.00421144130547721,0.00970019369435256,0.439349974609352
CASQ2,Calsequestrin-2,Blood and urine assays,X30830.SHBG,44405,0.00141872758444861,0.00411779573147737,-0.00665215204924704,0.00948960721814427,0.730446988515998
CASQ2,Calsequestrin-2,Blood and urine assays,X30840.Total bilirubin,46437,-0.00574720448858487,0.00346984943731072,-0.0125481093857139,0.00105370040854415,0.0976695597462831
CASQ2,Calsequestrin-2,Blood and urine assays,X30850.Testosterone,44699,-0.00702897371817197,0.00587617666967724,-0.0185462799907394,0.00448833255439543,0.231639355256425
CASQ2,Calsequestrin-2,Blood and urine assays,X30860.Total protein,44590,0.0104179766478376,0.00361712363196923,0.00332841432917788,0.0175075389664973,0.00397852018824272
CASQ2,Calsequestrin-2,Blood and urine assays,X30870.Triglycerides,46505,0.00602789620312735,0.0035482644573041,-0.00092670213318868,0.0129824945394434,0.0893650568175594
CASQ2,Calsequestrin-2,Blood and urine assays,X30880.Urate,46497,0.00187664386621479,0.00429928277881779,-0.00654995038026809,0.0103032381126977,0.662476992490193
CASQ2,Calsequestrin-2,Blood and urine assays,X30890.Vitamin D,45598,-0.00553597788699651,0.00370938656213765,-0.0128063755487863,0.00173441977479328,0.135602514255245
CASQ2,Calsequestrin-2,Physical measures,X3137.Number of measurements made,45687,-0.0683210085274881,0.0298790444135187,-0.126883935577985,-0.00975808147699143,0.0222295229245285
CASQ2,Calsequestrin-2,Physical measures,X3143.Ankle spacing width,37288,0.00910190249799667,0.0059329887893533,-0.00252675552913579,0.0207305605251291,0.125024284528153
CASQ2,Calsequestrin-2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",37287,-0.00444148914205856,0.00453071438242279,-0.0133216893316072,0.00443871104749011,0.326952467988496
CASQ2,Calsequestrin-2,Physical measures,X3146.Speed of sound through heel,37288,-0.00285062001739925,0.00441630536829542,-0.0115065785392583,0.00580533850445977,0.518629664122206
CASQ2,Calsequestrin-2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",37288,-0.00354263383131362,0.00445450344740518,-0.0122734605882278,0.00518819292560053,0.426457347728793
CASQ2,Calsequestrin-2,Physical measures,X3148.Heel bone mineral density (BMD),37278,-0.00326255959895091,0.00446745885573476,-0.012018778956191,0.00549365975828922,0.465223080576106
CASQ2,Calsequestrin-2,Health and medical history,X3526.Mother's age at death,33480,-0.00097646734201117,0.00603266806590829,-0.0128004967511914,0.0108475620671691,0.871416931889212
CASQ2,Calsequestrin-2,Health and medical history,X3581.Age at menopause (last menstrual period),29361,0.0038661715635037,0.00885696766329321,-0.013493485056551,0.0212258281835584,0.66248251343487
CASQ2,Calsequestrin-2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",29303,-0.0111167249462852,0.00772203165231235,-0.0262519069848174,0.00401845709224703,0.150034874589386
CASQ2,Calsequestrin-2,Physical measures,X4100.Ankle spacing width (left),31444,0.00989586673947798,0.00835456501634057,-0.00647908069254955,0.0262708141715055,0.236257785350666
CASQ2,Calsequestrin-2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),31444,-0.00149977173233268,0.00637988869000447,-0.0140043535647414,0.0110048101000761,0.814154508923149
CASQ2,Calsequestrin-2,Physical measures,X4103.Speed of sound through heel (left),31444,0.000640533097267215,0.00623622521122713,-0.011582468316738,0.0128635345112724,0.918194527988747
CASQ2,Calsequestrin-2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",31444,-7.21993098368184e-05,0.00628943017924928,-0.0123994824611654,0.0122550838414918,0.990841213156766
CASQ2,Calsequestrin-2,Physical measures,X4105.Heel bone mineral density (BMD) (left),31438,0.000501811335709401,0.00629896123407829,-0.011844152683084,0.0128477753545028,0.936505221038075
CASQ2,Calsequestrin-2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",31444,-6.36008824013852e-05,0.00628951069898071,-0.0123910418524036,0.0122638400876008,0.991932023515868
CASQ2,Calsequestrin-2,Physical measures,X4119.Ankle spacing width (right),31435,0.0108372573735181,0.00821900415898478,-0.00527199077809209,0.0269465055251282,0.187355822490488
CASQ2,Calsequestrin-2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),31435,0.00263320913949639,0.00642965549673695,-0.00996891563410802,0.0152353339131008,0.682154082404325
CASQ2,Calsequestrin-2,Physical measures,X4122.Speed of sound through heel (right),31435,0.00149109986862606,0.00624932172576331,-0.01075757071387,0.0137397704511221,0.811420766927339
CASQ2,Calsequestrin-2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",31435,0.0020863592292362,0.00631559362064609,-0.0102922042672301,0.0144649227257025,0.741144308668473
CASQ2,Calsequestrin-2,Physical measures,X4124.Heel bone mineral density (BMD) (right),31428,0.00256402629635278,0.00632948220774355,-0.00984175883082458,0.0149698114235301,0.685420908130121
CASQ2,Calsequestrin-2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",31435,0.00209343760491389,0.00631565367381718,-0.0102852435957678,0.0144721188055956,0.740300116522904
CASQ2,Calsequestrin-2,Physical measures,X4194.Pulse rate,31697,0.00496063691251263,0.00598318661168785,-0.00676640884639556,0.0166876826714208,0.407075259683608
CASQ2,Calsequestrin-2,Physical measures,X4195.Pulse wave reflection index,31697,-0.00386148780239103,0.00583197199437158,-0.0152921529113593,0.00756917730657727,0.507911315167252
CASQ2,Calsequestrin-2,Physical measures,X4196.Pulse wave peak to peak time,31692,-0.000484287258550646,0.00625045964619476,-0.0127351881650924,0.0117666136479911,0.938243470937604
CASQ2,Calsequestrin-2,Physical measures,X4198.Position of the pulse wave peak,31697,0.00504747886583074,0.00600931200921015,-0.00673077267222115,0.0168257304038826,0.400966033517187
CASQ2,Calsequestrin-2,Physical measures,X4199.Position of pulse wave notch,31697,0.00591557474978686,0.00591681426971475,-0.00568138121885405,0.0175125307184278,0.317442767882493
CASQ2,Calsequestrin-2,Physical measures,X4200.Position of the shoulder on the pulse waveform,31697,0.00457751436430054,0.00615330702732027,-0.00748296740924719,0.0166379961378483,0.456952467308689
CASQ2,Calsequestrin-2,Physical measures,X4269.Number of triplets attempted (left),31571,-0.157716633056761,0.120099910227383,-0.393112457102432,0.0776791909889096,0.189150696827712
CASQ2,Calsequestrin-2,Physical measures,X4270.Volume level set by participant (left),31495,0.00839672855795672,0.0407001055052428,-0.0713754782323193,0.0881689353482327,0.836556385846995
CASQ2,Calsequestrin-2,Physical measures,X4276.Number of triplets attempted (right),31580,0.0254323058072008,0.139087827072308,-0.247179835254523,0.298044446868925,0.854919980034543
CASQ2,Calsequestrin-2,Physical measures,X4277.Volume level set by participant (right),31494,-0.0435865855163446,0.0405599204444403,-0.123084029587448,0.0359108585547585,0.282577945346853
CASQ2,Calsequestrin-2,Cognitive function,X4288.Time to answer,31720,-0.0170323154714576,0.00688151744076234,-0.0305200896553518,-0.00354454128756343,0.0133415131974897
CASQ2,Calsequestrin-2,Cognitive function,X4290.Duration screen displayed,31720,-0.0105079876500061,0.00601025013606767,-0.0222880779166987,0.00127210261668652,0.0804434348750191
CASQ2,Calsequestrin-2,Physical measures,X46.Hand grip strength (left),47570,0.00525825785087537,0.00465870153060235,-0.00387279714910522,0.014389312850856,0.259037511115694
CASQ2,Calsequestrin-2,Physical measures,X47.Hand grip strength (right),47549,0.00532908866521003,0.00461502786331263,-0.00371636594688272,0.0143745432773028,0.248214651861274
CASQ2,Calsequestrin-2,Physical measures,X48.Waist circumference,47618,0.00218363290334609,0.00727616801485209,-0.012077656405764,0.0164449222124562,0.764097751647079
CASQ2,Calsequestrin-2,Health and medical history,X4803.Tinnitus,31528,0.0254747064582594,0.0499632605203158,-0.0724532841615595,0.123402697078078,0.610158078648419
CASQ2,Calsequestrin-2,Working and living environment,X4825.Noisy workplace,31654,-0.0157934902183646,0.055467949219164,-0.124510670687926,0.0929236902511969,0.77585717600335
CASQ2,Calsequestrin-2,Working and living environment,X4836.Loud music exposure frequency,31601,-0.0984338394515827,0.0640724019472542,-0.224015747268201,0.0271480683650356,0.124507963543964
CASQ2,Calsequestrin-2,Physical measures,X49.Hip circumference,47615,-0.00219560829410509,0.00574863985876545,-0.0134629424172854,0.00907172582907518,0.702512797544759
CASQ2,Calsequestrin-2,Physical measures,X50.Standing height,47593,7.58843520142946e-05,0.00457272971242565,-0.00888666588433997,0.00903843458836856,0.986759869949452
CASQ2,Calsequestrin-2,Health and medical history,X5057.Number of older siblings,31001,-0.0629253243263043,0.0431943113480976,-0.147586174568576,0.021735525915967,0.14521651863595
CASQ2,Calsequestrin-2,Physical measures,X51.Seated height,47480,0.0019323281959298,0.00423420435902535,-0.00636671234775988,0.0102313687396195,0.648134183955661
CASQ2,Calsequestrin-2,Eye measures,X5181.Ever had eye surgery,29199,-0.121683359046094,0.117769043141911,-0.35251068360424,0.109143965512052,0.301539714375683
CASQ2,Calsequestrin-2,Eye measures,X5186.Duration visual-acuity screen displayed (right),29188,-0.00056321992108098,0.00747500034084706,-0.0152142205891412,0.0140877807469793,0.939941341984053
CASQ2,Calsequestrin-2,Eye measures,X5188.Duration visual-acuity screen displayed (left),29187,0.00166618770017192,0.00739962038353506,-0.0128370682515568,0.0161694436519006,0.821854068202812
CASQ2,Calsequestrin-2,Eye measures,X5190.Duration at which refractometer first shown (right),29139,0.00308730630315816,0.00730079746946784,-0.0112222567369988,0.0173968693433151,0.672405529676945
CASQ2,Calsequestrin-2,Eye measures,X5193.Duration at which refractometer first shown (left),29138,0.00178213839307001,0.00733290754880432,-0.0125903604025865,0.0161546371887265,0.807989290957309
CASQ2,Calsequestrin-2,Eye measures,"X5199.logMAR, initial (right)",29164,0.000779468203013053,0.0502380072588732,-0.0976870260243785,0.0992459624304046,0.987621496064419
CASQ2,Calsequestrin-2,Eye measures,X5200.Final number of letters displayed (right),29164,-0.303952926694476,0.273065050043987,-0.83916042478069,0.231254571391737,0.265709310284093
CASQ2,Calsequestrin-2,Eye measures,"X5201.logMAR, final (right)",29121,0.00688714453978288,0.00708200542952453,-0.00699358610208519,0.020767875181651,0.33085399819241
CASQ2,Calsequestrin-2,Eye measures,X5202.Number of rounds to result (right),29164,-0.0410720768998362,0.0475952202520725,-0.134358708593898,0.0522145547942259,0.388206579369995
CASQ2,Calsequestrin-2,Eye measures,"X5206.logMAR, initial (left)",29164,0.0564989915605278,0.0488564821943055,-0.039259713540311,0.152257696661367,0.247558330967743
CASQ2,Calsequestrin-2,Eye measures,X5207.Final number of letters displayed (left),29164,0.888760809856182,0.549930505685329,-0.189102981287062,1.96662460099943,0.106125066448358
CASQ2,Calsequestrin-2,Eye measures,"X5208.logMAR, final (left)",29121,0.0118331645596242,0.00717662115036039,-0.00223301289508219,0.0258993420143305,0.0992382808944666
CASQ2,Calsequestrin-2,Eye measures,X5209.Number of rounds to result (left),29160,0.00889795872098003,0.0475660161811083,-0.0843314329939923,0.102127350435952,0.851616483723809
CASQ2,Calsequestrin-2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",28963,0.00303753027615352,0.00730256289261082,-0.0112754929933637,0.0173505535456707,0.677461152146477
CASQ2,Calsequestrin-2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",28963,0.00402300197888195,0.00718458647956038,-0.0100587875210564,0.0181047914788203,0.5755388063608
CASQ2,Calsequestrin-2,Eye measures,X5256.Corneal hysteresis (right),28963,0.00233187697995314,0.00733054804208403,-0.0120359971825316,0.0166997511424378,0.750419032574576
CASQ2,Calsequestrin-2,Eye measures,X5257.Corneal resistance factor (right),28963,0.00490391828226857,0.00720180576019865,-0.00921162100772077,0.0190194575722579,0.495947322725981
CASQ2,Calsequestrin-2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",28942,0.00670728291712725,0.00738104082257751,-0.00775955709512466,0.0211741229293792,0.363542215552972
CASQ2,Calsequestrin-2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",28942,0.00599745661898421,0.00725905934980328,-0.00823029970663022,0.0202252129445986,0.408727731780951
CASQ2,Calsequestrin-2,Eye measures,X5264.Corneal hysteresis (left),28942,-0.000723759362532671,0.00734395868658445,-0.0151179183882382,0.0136703996631728,0.921498134928695
CASQ2,Calsequestrin-2,Eye measures,X5265.Corneal resistance factor (left),28942,0.00168405172995306,0.00723281454782377,-0.0124922647837815,0.0158603682436876,0.815898979379515
CASQ2,Calsequestrin-2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,28979,-0.566463717828484,0.278093108642597,-1.11152621076797,-0.0214012248889939,0.041705699058549
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",47542,-0.0394625089175523,0.0195330131234491,-0.0777472146395124,-0.00117780319559212,0.0433637129520007
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",47542,-0.0164159198285898,0.0216274030644332,-0.0588056298348788,0.0259737901776993,0.447840171875113
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",47542,-0.0795776219026045,0.053636648732144,-0.184705453417607,0.0255502096123977,0.137917045290403
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",47542,0.013488965953986,0.00912603065622198,-0.00439805413220905,0.0313759860401811,0.139400763590436
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",47542,-0.00547273722969989,0.00818431745892431,-0.0215139994491915,0.0105685249897918,0.503702417069768
CASQ2,Calsequestrin-2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",35679,0.0032505163898905,0.00917872137041434,-0.0147397774961216,0.0212408102759026,0.723243222717629
CASQ2,Calsequestrin-2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",35679,-0.0123844386088359,0.0316622720121272,-0.0744424917526052,0.0496736145349334,0.695699462990268
CASQ2,Calsequestrin-2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",35679,-0.00588565890345414,0.0156962990278661,-0.0366504049980717,0.0248790871911634,0.70768866960714
CASQ2,Calsequestrin-2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",35679,0.0141603002686376,0.00992566239570107,-0.0052939980269365,0.0336145985642117,0.153711460841172
CASQ2,Calsequestrin-2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,47609,-0.0277311636344077,0.0183404738954474,-0.0636784924694846,0.00821616520066915,0.13054207638713
CASQ2,Calsequestrin-2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,47609,-0.0277311636344077,0.0183404738954474,-0.0636784924694846,0.00821616520066915,0.13054207638713
CASQ2,Calsequestrin-2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),47609,-0.0107499874486324,0.0135878217363046,-0.0373821180517894,0.0158821431545247,0.428865126404963
CASQ2,Calsequestrin-2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',47609,0.00934083970788125,0.0211787207046198,-0.0321694528731735,0.050851132288936,0.659182013123605
CASQ2,Calsequestrin-2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),47609,-0.0336116933321256,0.0517284956954213,-0.134999544895151,0.0677761582309001,0.515846226738856
CASQ2,Calsequestrin-2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),47609,0.0173899555142966,0.0372757446065864,-0.0556705039146127,0.0904504149432058,0.640846171871428
CASQ2,Calsequestrin-2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,47609,0.049686454764955,0.0554208753612107,-0.058938460943018,0.158311370472928,0.369979070443745
CASQ2,Calsequestrin-2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,47541,-0.0095990768383524,0.010463380679019,-0.0301073029692296,0.0109091492925248,0.358943847179805
CASQ2,Calsequestrin-2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,47541,0.035493051888056,0.0179832005859416,0.00024597873961054,0.0707401250365015,0.0484299454874441
CASQ2,Calsequestrin-2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,47541,0.017643139563459,0.00877049138674194,0.00045297644544481,0.0348333026814732,0.0442683846734297
CASQ2,Calsequestrin-2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,47541,0.00424813907128254,0.0164459416597218,-0.0279859065817721,0.0364821847243372,0.796170482685279
CASQ2,Calsequestrin-2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,47541,0.0192736033758809,0.0143231102964538,-0.00879969280516855,0.0473468995569303,0.178434834462702
CASQ2,Calsequestrin-2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,47541,0.00483914141322019,0.0115866448279893,-0.0178706824496388,0.0275489652760792,0.676208133323586
CASQ2,Calsequestrin-2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,29096,-0.0436472734709874,0.0307351721685078,-0.103888210921263,0.0165936639792879,0.155635688616986
CASQ2,Calsequestrin-2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,29096,-0.0564557747090674,0.0270382990553001,-0.109450840857456,-0.00346070856067922,0.0368466879247417
CASQ2,Calsequestrin-2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,29096,0.00227349939799201,0.0335117118232369,-0.0634094557755523,0.0679564545715363,0.945914051175164
CASQ2,Calsequestrin-2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,29096,0.0314964861663237,0.0275844542656312,-0.0225690441943134,0.0855620165269609,0.253580991787458
CASQ2,Calsequestrin-2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,47499,0.0244090914075002,0.0288574319107348,-0.0321514751375399,0.0809696579525403,0.397644359345839
CASQ2,Calsequestrin-2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,47499,-0.0132095176952701,0.0421694160553673,-0.09586157316379,0.0694425377732498,0.754094432319725
CASQ2,Calsequestrin-2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,47499,-0.0679521303889246,0.0869251635389065,-0.238325450925181,0.102421190147332,0.434380269414459
CASQ2,Calsequestrin-2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,47499,-0.0823168227571188,0.0706146383586517,-0.220721513940076,0.0560878684258386,0.243739853655404
CASQ2,Calsequestrin-2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,47499,-0.0242384476087694,0.0268296469684644,-0.0768245556669597,0.0283476604494209,0.366312078023362
CASQ2,Calsequestrin-2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,47499,-0.00440988274937175,0.0344990149301911,-0.0720279520125462,0.0632081865138027,0.898287493514505
CASQ2,Calsequestrin-2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,47499,-0.000324747981116982,0.014022848329021,-0.0278095307059982,0.0271600347437643,0.98152404603271
CASQ2,Calsequestrin-2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",32070,0.011616348022191,0.0261829987351437,-0.0397023294986907,0.0629350255430727,0.657300143771185
CASQ2,Calsequestrin-2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",32070,0.0186681735746921,0.0292933112483285,-0.0387467164720317,0.0760830636214159,0.52395730764512
CASQ2,Calsequestrin-2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",32070,-0.00631020622355152,0.0373983770274335,-0.0796110251973212,0.0669906127502182,0.866013638334583
CASQ2,Calsequestrin-2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",32070,-0.00380488125545696,0.0113155151297079,-0.0259832909096844,0.0183735283987705,0.736688326144412
CASQ2,Calsequestrin-2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",33856,0.00164912139072911,0.0122278135298659,-0.0223173931278081,0.0256156359092663,0.892720208148356
CASQ2,Calsequestrin-2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",33856,0.00361392507197309,0.0099139278322855,-0.0158173734793065,0.0230452236232527,0.71546991458739
CASQ2,Calsequestrin-2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",33856,-0.00608498089520358,0.00979337511042524,-0.0252799961116371,0.0131100343212299,0.534392446275168
CASQ2,Calsequestrin-2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",33857,0.0220280571896057,0.0236314434760909,-0.0242895720235325,0.0683456864027439,0.351281365648358
CASQ2,Calsequestrin-2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",33857,-0.0271617212091868,0.0153683057290198,-0.0572836004380657,0.00296015801969213,0.0771941864799195
CASQ2,Calsequestrin-2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",33857,-0.0336279240068839,0.0194919091170767,-0.0718320658763543,0.00457621786258647,0.0845178822516412
CASQ2,Calsequestrin-2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,47541,-0.00534731272362327,0.0244091099850967,-0.0531891682944128,0.0424945428471663,0.826597120482254
CASQ2,Calsequestrin-2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,47541,0.0290243735440818,0.0157236800111821,-0.00179403927783517,0.0598427863659987,0.0649188985121202
CASQ2,Calsequestrin-2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,47541,-0.00471746447542649,0.0488620264605064,-0.100487036338019,0.091052107387166,0.92308725058605
CASQ2,Calsequestrin-2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,47541,0.0242769708500816,0.0178858424338834,-0.0107792803203299,0.059333222020493,0.174689663605876
CASQ2,Calsequestrin-2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,47541,0.0100783041276177,0.0196835264128378,-0.0285014076415444,0.0486580158967797,0.608643744927871
CASQ2,Calsequestrin-2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),47541,0.0131513647560897,0.021532207737298,-0.0290517624090143,0.0553544919211937,0.541353467903654
CASQ2,Calsequestrin-2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,47541,-0.00578601021147656,0.00703120061170891,-0.019567163410426,0.0079951429874729,0.410570299546529
CASQ2,Calsequestrin-2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,27462,0.018057386369691,0.0228413154299251,-0.0267115918729623,0.0628263646123443,0.429253965002782
CASQ2,Calsequestrin-2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,27462,-2.85928680546282e-05,0.0291221615361172,-0.0571080294788444,0.0570508437427351,0.999216671437047
CASQ2,Calsequestrin-2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,27462,-0.0199037122145896,0.021469557097382,-0.0619840441254583,0.0221766196962791,0.353953997932304
CASQ2,Calsequestrin-2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,27462,0.0213457933067818,0.0179324423071206,-0.0138017936151747,0.0564933802287382,0.233989258670262
CASQ2,Calsequestrin-2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,47653,-0.00835019729488475,0.00754137514177016,-0.0231312925727543,0.00643089798298477,0.268196494899509
CASQ2,Calsequestrin-2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,47653,-0.0366370708408062,0.0221024222192763,-0.0799578183905878,0.00668367670897538,0.0974105378327483
CASQ2,Calsequestrin-2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,47653,-0.00555697124232014,0.00760229483925566,-0.0204574691272612,0.00934352664262096,0.464810959825252
CASQ2,Calsequestrin-2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,47653,0.00970070726939901,0.0073835479550619,-0.00477104672252232,0.0241724612613203,0.188916977650774
CASQ2,Calsequestrin-2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,47653,0.021559096885192,0.0107263154522355,0.000535518598810337,0.0425826751715737,0.0444503221301264
CASQ2,Calsequestrin-2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,47653,0.0181951070536196,0.0109089953052964,-0.00318652374476126,0.0395767378520005,0.0953488519964337
CASQ2,Calsequestrin-2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,47653,0.0011085435904405,0.00815492366089297,-0.0148751067849097,0.0170921939657907,0.891873424388951
CASQ2,Calsequestrin-2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,47653,-0.0149520098570118,0.0229636445096356,-0.0599607530958975,0.0300567333818739,0.514977517562725
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,39969,0.007691164821978,0.00775960139024774,-0.00751765390290758,0.0228999835468636,0.321612386189975
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,39969,0.00332472754339849,0.00814761393285082,-0.0126445957649891,0.0192940508517861,0.683233949478485
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,39969,-0.00265059517783131,0.00972800016323453,-0.021717475497771,0.0164162851421084,0.785263596644204
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,39970,-0.018837972116294,0.0133891526742261,-0.0450807113577771,0.00740476712518914,0.159459208650158
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,39970,0.00784218152106441,0.00860951509269173,-0.00903246806061137,0.0247168311027402,0.362375513020766
CASQ2,Calsequestrin-2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,47450,-0.00233043891387793,0.00833003781431646,-0.0186573130299382,0.0139964352021823,0.779661558755211
CASQ2,Calsequestrin-2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,47450,0.00257845299490732,0.00653864623464369,-0.0102372936249943,0.015394199614809,0.693333234208622
CASQ2,Calsequestrin-2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,47450,0.00176659130613239,0.00779292332770096,-0.0135075384161615,0.0170407210284263,0.820665418933818
CASQ2,Calsequestrin-2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,47450,-0.00129851378253282,0.012147985617583,-0.0251085655929954,0.0225115380279298,0.914876136773788
CASQ2,Calsequestrin-2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),47465,0.00847137451298573,0.0071643927183343,-0.00557083521494949,0.022513584240921,0.23704805240287
CASQ2,Calsequestrin-2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,47465,0.00956823876671093,0.00995126158859973,-0.00993623394694455,0.0290727114803664,0.336305586384304
CASQ2,Calsequestrin-2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),47541,0.00135609113542735,0.00758508097757929,-0.0135106675806281,0.0162228498514828,0.858108836587705
CASQ2,Calsequestrin-2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,47541,0.00388988615767283,0.00940009220375619,-0.0145342945616893,0.022314066877035,0.679014358006819
CASQ2,Calsequestrin-2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,47541,0.00426189734529555,0.0139396104047631,-0.0230597390480401,0.0315835337386313,0.759805255563386
CASQ2,Calsequestrin-2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,47541,0.0113629431016084,0.0166023804049231,-0.0211777224920409,0.0439036086952577,0.493718897114581
CASQ2,Calsequestrin-2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,47541,0.0297338640535249,0.0159999209377127,-0.00162598098439191,0.0610937090914418,0.0631280817284909
CASQ2,Calsequestrin-2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,47541,0.00215437796189559,0.0233280394636892,-0.0435685793869352,0.0478773353107264,0.926419603488547
CASQ2,Calsequestrin-2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",37288,-0.00354539360299592,0.00445453231568495,-0.0122762769417384,0.00518548973574658,0.426100142083922
CASQ2,Calsequestrin-2,Physical activities,X864.Number of days or week walked 10+ minutes,47208,-0.0085337152170563,0.023990363966583,-0.0555548285915591,0.0384873981574465,0.722057758828279
CASQ2,Calsequestrin-2,Physical activities,X874.Duration of walks,44131,0.00315506471328451,0.00336226064651542,-0.00343496615388571,0.00974509558045473,0.348062392927241
CASQ2,Calsequestrin-2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,46582,-0.00931845165136119,0.023351709199553,-0.055087801682485,0.0364508983797626,0.689861625605647
CASQ2,Calsequestrin-2,Physical activities,X894.Duration of moderate activity,41463,-0.000166555637062421,0.028435288011694,-0.0558997201399826,0.0555666088658577,0.995326598277913
CASQ2,Calsequestrin-2,Physical activities,X90087.No-wear time bias adjusted average acceleration,29097,-0.00589980241545784,0.00704771194155942,-0.0197133178209143,0.00791371298999862,0.402561579658047
CASQ2,Calsequestrin-2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,46581,0.0548978219713369,0.0239792833278651,0.0078984266487212,0.101897217293953,0.022066097393363
CASQ2,Calsequestrin-2,Physical activities,X914.Duration of vigorous activity,37250,0.00396840688323587,0.00441653948205769,-0.00468801050159721,0.0126248242680689,0.368917567111171
